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8Chapter 1
1.  Anatomy of the lower urinary tract
The function of the lower urinary tract is storage of urine and emptying of the stored 
urine at an appropriate moment and place. This requires an interplay of relaxation and 
contraction of the bladder and bladder outlet. 
1.1. The bladder
Traditionally, is was thought that the human urinary bladder is a hollow musculous organ 
that is primarily formed by smooth muscle. In more  detail, the bladder wall was thought 
to consist of four layers.
The interior side of the bladder is lined by a protective boarder of mucosa, also called 
the urothelium. This layer consists of five to seven strata of transitional epithelial cells, 
also called urothelial cells. Urothelial cells prevent substances in the urine from crossing 
into the underlying layers of the bladder wall, thus serving a protective function. The 
submucosa, also known as the lamina propria, is a layer of elastic connective tissue that 
allows the bladder to stretch as it fills. It consists of blood and lympathic vessels and 
nerves within a stroma of fibrous connective tissue that join the urothelium to the inner 
layers. Adjacent to and outward of the submucosa is the muscle layer of the bladder, 
also known as the tunica muscularis or the detrusor muscle. It consists of three layers of 
muscle bundles. The inner and outer layer muscle bundles course mainly longitudinally. 
The layer in between has a circulatory orientation. All bundles branch off and meet 
elsewhere, hereby producing a dense wickerwork of muscle bundles that is heavily 
innervated. The outermost layer, known as the serosa is derived from the peritoneum and 
covers the bladder. 
However, in the last decade is has become more and more clear that the human urinary 
bladder cannot merely be seen as a passive hollow musculous ‘black box’, solely controlled 
by neuronal input. Local bladder regulatory factors play a major part. This will be discussed 
further on in this thesis.
1.2. The bladder outlet
 
The male urethra is a fibromuscular tube of approximately 20cm long. At the male bladder 
neck, the internal urinary sphincter forms a complete circular collar. It is made of smooth 
muscle. It therefore is under involuntary or autonomic control. It is the primary muscle for 
prohibiting the release of urine, but also plays a major role in preventing semen influx at 
ejaculation. Distally, the bladder neck muscle merges with, and becomes indistinguishable 
from, the musculature in the stroma and capsule of the prostate gland. 
In females, there is no anatomical internal smooth muscle sphincter at the bladder neck, 
as the muscle bundles in the female bladder neck extend obliquely or longitudinally into 
the urethral wall. 
The external urinary sphincter is made up from a intrinsic and extrinsic component. The 
rhabdosphincter is the internal component and located in the walls of the male and female 
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urethra. It is made of striated muscle and therefore under voluntary or somatic control. 
This muscle is also called the intrinsic sphincter externus.  Besides the urethra wall, the 
levator ani pelvic floor muscle forms an important effective contractile support structure. 
It is also known as the extrinsic sphincter externus. Contraction of the musculus levator 
ani is responsible for the compression of the urethra. In doing so, this muscle assists the 
rhabdosphincter to ensure continence.
2. Neuronal bladder control and physiology
The neural control of the lower urinary tract is distinct from other visceral organs such as 
the heart, blood vessels and the intestine. These are regulated exclusively by involuntary 
(autonomic) reflex mechanisms. Bladder storage and emptying, as well as coordinated 
contraction or relaxation of the urinary sphincter can be seen as a peripheral urinary 
reflex system that is mediated by neural circuits from the brain and spinal cord. 
2.1. The peripheral urinary reflex system
The peripheral system consists of three sets of peripheral nerves: the pelvic nerves, the 
hypogastric nerves and the pudendal nerves. They contain both afferent (sensory) and 
efferent (motor) nerve fibres. Under additional sympathetic and parasympathetic control, 
the central and peripheral nervous system control the bladder and urethra as a functional 
unit. In general, urinary storage is a function of the sympathetic nervous system, whereas 
micturition is a function of the parasympathetic nervous system. Both are autonomic 
functions in nature. The somatic nervous system is responsible for the control of the 
external urinary sphincter, allowing for volitional continence. 
Figure 1 - Diagram illustrating 
the functional characteristics 
of the efferent pathways of the 
hypogastric, pelvic and puden-
dal nerves (bron Urol N&A).
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Sympathetic afferent neurons are conducted via the hypogastric plexus and projects to the 
spinal levels Th11-L2 [1, 2]. They contain A-delta fibres ( for sensation of bladder filling) 
and C-fibres (for sensations of noxious stimuli). The afferent information is also projected 
to the brain [3]. These neurons are active during the filling phase.
Sympathetic efferent neurons of the hypogastric plexus originate from the spinal level 
Th11-L2,  pass the paravertebral sympathetic chain ganglia or the inferior mesenteric 
ganglia and connect with the pelvic and intramural ganglia of the bladder wall [4]. These 
neurons are active during the filling phase, which results in relaxation of the bladder dome 
and contraction of the bladder outlet [5,6].
Parasympathetic afferent neurons are conducted via the pelvic plexus and pelvic nerve 
to the sacral intermediate gray in the spinal cord S2-4. Here, they connect to efferent 
parasympathetic fibres to form a reflex arc. The afferent information is also projected 
to the brain. Most of the information of the bladder and urethra reaches the spinal cord 
via the pelvic nerve. This is in accordance to the finding that the bladder base contains a 
much higher level of afferent nerve endings than the bladder dome.
Parasympathic efferent neurons of the pelvic nerve originate from the sacral 
parasympathetic nucleus at spinal cord level S2-4. They synapse with the postganglionic 
nerve in the pelvic plexus or ganglia in the bladder wall. These neurons are active during 
the micturition phase, resulting in contraction of the bladder dome and relaxation of the 
bladder outlet [7]. 
Somatic neurons originate from the nucleus of Onuf at the spinal levels S2-4, pass through 
the pudendal nerves and innervate the rhabdosphincter [8]. Activation of these fibres 
results in relaxation of the sphincter [9].
2.2. Bladder control: mediation by the brain and spinal cord
The bladder has a continuous biphasic cycle consisting of a storage and micturition 
phase. As mentioned previously, the peripheral urinary reflex system is mediated by 
neural circuits from the brain and spinal cord. In infants these mechanisms function 
purely in a reflex manner to produce involuntary voiding. However, in adults urine 
storage and release are under voluntary control.
2.2.1 Storage phase
During urine storage, a low level of afferent (sensory) activity from the bladder is 
transported via the pelvic plexus and pelvic nerve to the spinal cord. These fibres are 
connected to efferent (motory) fibres to form a reflex arc. They activate efferent input 
to the urethral sphincter, resulting in contraction and hereby preserving continence. By 
bladder distension, the afferent activity from the bladder rises until a certain threshold 
tension is achieved.
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2.2.2 Micturition phase
Afferent information from the bladder is also projected to the brain. This information 
is relayed in the periaqueductal gray (PAG). The PAG receives input from multiple brain 
regions, such as the hypothalamus, amygdala and the prefrontal and orbital cortex [10]. 
The PAG plays a major role in the micturition cycle. The decision to void is taken in the PAG. 
The PAG conveys the ‘safe signal to void’ based upon its incoming information from the 
bladder, cortical system and limbic system associated structures. The PAG communicates 
with the pontine micturition center (PMC), also located in the brain stem. The PMC can be 
seen as a regulator of a complex urinary reflex system, resulting in an accurate interplay of 
the bladder and bladder outlet. It functions as a ‘ON/OFF’ switch and consists of a L- and 
M-region. The L-region can be seen as a pontine storage center. The M-region can be seen 
as a pontine micturition center. Activating the M-region produces firing in the efferent 
pathways to the bladder and urethral outlet. The urethral sphincter and pelvic floor relax 
and the detrusor muscle contracts. Once the bladder is emptied, the pontine storage 
center is activated, the PMC returns into ‘OFF’ mode and the micturition cycle continues. 
3. Receptors at the bladder neuromuscular junction
3.1. Urinary storage; the adrenergic system
In general, urinary storage is coordinated by the sympathetic nervous system. Adrenergic 
receptors are stimulated by the sympathetic nervous system. Different types of adrenergic 
muscle receptors are found within the bladder and bladder outlet. The bladder dome 
houses mainly b-adrenergic receptors (b3 subtype) [11]. In the trigonum (base of 
bladder) and bladder neck a majority of  a-adrenergic receptors is found (a1d subtype) 
[12]. Stimulation of b-adrenergic receptors results in muscle relaxation. Stimulation of 
a-adrenergic receptors results in muscle contraction. In theory, sympathetic stimulation 
contracts the bladder neck while the rest of the bladder is relaxated. In practice however, 
Figure 2 - Diagram illustrating 
the anatomy of the lower uri-
nary tract and the switchlike 
function of the micturition 
reflex pathway. A high level of 
afferent activity induced by 
bladder distention activates 
the switching circuit in the 
central nervous system (CNS), 
producing firing in the efferent 
pathways to the bladder, inhi-
bition of the efferent outflow 
to the urethral sphincter, and 
urine elimination.
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the true role for sympathetic nerve system is probably overestimated, because bladder 
dysfunction has never been found after lumbal sympathectomy. Retrograde ejaculation 
however, is found. Which suggests a role for the sympathetic nervous system in the 
regulation of the internal urethral sphincter. The rabdosphincter is under somatic control 
by cholinergic receptors. 
3.2. Voiding; the cholinergic system
Parasympathetic impulses travel to the bladder along the efferent fibres of the pelvic 
nerves resulting in stimulation of muscarinic receptors leading to contraction of the bladder 
dome [13]. These cholinergic receptors are widely distributed throughout the human 
body, explaining the associated side effects of antimuscarinic agents. The muscarinic 
receptor subtype 3 (M3) is responsible for the emptying contraction during voiding [14]. 
In the neurogenic dysfunctional bladder, an increased expression of M2 receptors is seen. 
M2 receptors prevent formation of cyclic adenosine monophosphate (cAMP), which 
mediates detrusor relaxation. However, the effect of parasympathetic nerve stimulation 
cannot totally be blocked by the parasympathicolyticum atropine, suggesting attributive 
pathways in bladder innervations. 
4. Lower urinary tract dysfunction and terminology
The urinary bladder and urethra form a functional unit which is controlled by a complex 
interplay between the central and peripheral nervous systems accompanied by local 
bladder regulatory factors. Malfunction at these various levels may result in lower urinary 
tract symptoms (LUTS),  which can roughly be classified as disturbances of filling/storage 
or  disturbances of emptying.
Failure to store urine may lead to various forms of incontinence (urge and stress 
incontinence), and failure to empty can lead to urinary retention, which may result in 
overflow incontinence. The most common problem with urine storage arises when the 
bladder fails to remain relaxed until an appropriate time for urination. This syndrome is 
called overactive bladder (OAB).
The first involuntary detrusor contractions probably were recorded towards the end of 
the 19th century during the early recordings of human bladder pressures (Dubois, 1876; 
Genouville, 1894). Unstable bladder contractions associated with bladder dysfunction 
were seen during World War 1 in soldiers suffering from spinal cord injuries or exposure 
to severe cold. Complaints of urge incontinence were accompanied by phasic pressure 
rises which were seen using urodynamics (Schwarz, 1915).
The terms unstable bladder and detrusor hyperreflexia were introduced 30 years ago. 
The Englishman Bates used the term unstable bladder to describe unvoluntary detrusor 
contractions seen during urodynamic studies as the bladder was filled. At the same time 
the Scandinavians, the other major innovators in urodynamics, were using the term 
detrusor hyperreflexia. To resolve this conflict the International Continence Society (ICS) 
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decided to use the term unstable bladder for involuntary contractions seen in patients 
with no obvious cause for the contractions. The term detrusor hyperreflexia however 
was used to describe patients whose involuntary contractions had a neurologic cause. In 
addition, the term overactive detrusor was used as the generic, overarching name.
The terms overactive bladder (OAB) and  detrusor overactivity (DO) were introduced in 
1999 by the International Continence Society (ICS). OAB is defined as urgency, with or 
without incontinence, usually with frequency and nocturia. The key symptom of OAB 
is urgency. Detrusor overactivity is a urodynamic observation (UDO) characterized by 
unvoluntary detrusor contractions during the filling phase, which may be spontaneous 
or provoked. 
5. Correlation between symptomatic diagnosis of OAB and detrusor overactivity
OAB symptoms are suggestive of urodynamically demonstrable detrusor overactivity 
(involuntary detrusor contraction) during the filling phase which may be spontaneous 
provoked. However, involuntary contractions do not always cause urgency and urgency is 
not always caused by involuntary contractions. Indeed, involuntary contractions are found 
in asymptomatic subjects. They were found in 25% of 13 asymptomatic middle aged men 
[15].
Urgency occurs in 70% of patients with normal urodynamics and in 85% of those with 
instability, suggesting that it cannot distinguish between the two groups. Futhermore, 
the success of predicting instability from the symptoms was only 31-48% in women and 
53% in men [16]. This suggests that the filling symptoms of unstable patients may not 
necessarily be caused by unstable contractions. This is important when considering the 
effects of  treatment, because abolishing unstable contractions may not resolve all filling 
symptoms.
It is important to know that the diagnosis of OAB can only be made when other known 
pathologies, such as a proven infection, a bladder stone or bladder cancer, can be excluded.
Figure 3 - Overactive bladder disease is a 
symptomatic diagnosis. Ring diagram sho-
wing that approximately half of individuals 
with urgency have coexisting urge inconti-
nence, and almost all have coexisting daytime 
and nighttime frequency.
Boek 17.indb   13 12-5-2014   21:37:25
14
Chapter 1
6. Socioeconomic relevance of OAB
The OAB is a common disorder affecting the quality of life in huge numbers of people 
worldwide [17]. It is associated with significant problems for patients, not just physical 
limitations, but socially, physiologically and sexually as well. In addition, there are large 
economic costs involved.
OAB is often confused with incontinence, making epidemiologic incidence data vary widely. 
It is difficult to estimate the true prevalence of bladder overactivity for two reasons: (1) 
relatively few patients with the disease seek treatment, despite the considerable impact 
of bladder storage symptoms on quality of life. These patients remain uncounted. (2) Few 
epidemiologic surveys have been carried out on the symptoms of urgency and frequency 
alone without incontinence. Surveys on the prevalence of urinary incontinence have been 
done, and estimates of the prevalence of bladder overactivity have been obtained by 
adding together the fraction of urge incontinent patients to the number of those with 
mixed incontinence. Thus, the most prevalent figures that are available significantly 
underestimate the extent of the problem. In reality, OAB is probably more prevalent than 
asthma and heart disease and nearly as prevalent as arthritis and chronic sinusitis.
The majority of people with chronic symptoms of bladder overactivity complains of 
frequency and urgency, while only a third complains of urge incontinence. The total 
prevalence of OAB within the general population aged 40 years and over ranges from 12% 
to 22% in a group of 17 000 people in 6 European countries [18]. The risk of developing 
OAB increases with age. In the group of people 75 years and older, the prevalence ranges 
between 30% and 40%. In the USA, the costs of OAB are on the same level with those 
for depression (44 billion US dollars) and Alzheimer disease (100 billion US dollars). In 
US women, urinary incontinence accounts for more direct costs than breast cancer, the 
number one type of cancer in women, and similar to osteoporosis.
It is certain that the clinical impact of this syndrome will be tremendous as the world 
population ages. By 2020, 44% of the world population will be older than 65 years of age, 
and the already huge financial burden will become critical in the future.
Figure  4. - Diagram demonstrating cor-
relation between symptomatic diagnosis 
of overactive bladder disease (OAB) and 
urodynamic diagnosis of detrusor overac-
tivity (pink ellipse). The correlation is gre-
atest for urge incontinence and poorest 
for frequency (day and/or night).
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7. Causes of the overactive bladder and detrusor overactivity
Because of the complexity of the nervous control of the lower urinary tract, there still is 
no consensus about the reason for developing an overactive bladder (OAB) and detrusor 
overactivity (DO). Detrusor overactivity can occur as a result of a variety of neurological 
disorders resulting in  changes in the innervation and muscle components of the bladder. 
Injuries or diseases of the nervous system in adults can disrupt the voluntary control 
of micturition causing the reappearance of reflex micturition, resulting in detrusor 
overactivity and possible incontinence. Overactive bladder may occur in patients due to 
changes in the brain or nerves (Multiple Sclerosis, Cerebrovasculair accident, Parkinson’s 
disease, brain tumors, Diabetes Mellitus). The aging bladder as well as patients with 
urethral outlet obstruction (e.g. prostate enlargement) or in those who are taking drugs 
that depress the neural control of the bladder are possible victims. 
Experimental studies indicate that detusor overactivity occurs after: (1) interruption of 
cortical inhibitory circuits, (2) disruption of basal ganglia function in models of Parkinson’s 
disease, (3) damage to pathways from the brain to the spinal cord (multiple sclerosis, 
spinal cord injury) and (4) sensitization of bladder afferents [19].
Theoretically, there may be 1) decreased inhibitory control in the central nervous system 
(CNS), 2) decreased inhibitory control in the peripheral ganglia, 3) increased afferent 
activity (sensitization), 4) increased sensitivity to efferent stimulation in the detrusor 
muscle or 5) a combination of these factors. 
8. Treatment of the OAB
8.1. Behavioural therapy
Conservative management forms the first line of treatment and includes lifestyle 
modifications, bladder training and pelvic floor exercises. If this fails, pharmacotherapy, in 
the form of anticholinergic drugs, is initiated.
8.2. Pharmacotherapy
Pharmacotherapy and behavioral therapy are the mainstays of treatment of OAB.  Although 
there are multiple central and peripheral sites and mechanisms that can influence bladder 
function, few are clinically useful. The problems are: (1) how to affect bladder function 
without interfering with the function of other organ systems (uroselectivity) and (2) 
how to eliminate overactivity without disturbing normal micturition. Multiple types of 
drug therapies are potentially useful for decreasing bladder contractility or decreasing 
sensation, but antimuscarinic medication (anticholinergica) have represented the 
current mainstay of pharmacotherapy for improving OAB symptoms. Reductions in OAB 
incontinence episodes with anticholinergic therapy range from 40% to 70% [20]. However, 
not all patients show adequate respons and the problem with current anticholinergics is 
the incidence of side effects such as dry mouth, blurred vision, constipation and voiding 
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difficulties with significant amounts of residual urine. These effects are significant enough 
to cause the patient to discontinue taking the medication [21]. In one study, it was 
estimated that only approximately 18% of patients remained on anticholinergic therapy 
for over 6 months [22]. Interestingly, a group of patients with OAB seems to respond to 
antimuscarinic treatment irrespective of the presence of DO [23]. This is in accordance with 
the increasing body of evidence that the mechanism of antimuscarinics on OAB symptoms 
could be on bladder sensory pathways rather than on motor pathways [24,25,26]. There 
are many antimuscarinic drugs, for example oxybutynin, tolterodine and trospium chloride. 
Each has a different specificity to bladder muscarinic receptors, thus producing different 
adverse effect profiles. New anticholinergic drugs, that have undergone phase III trials 
and are more specific to the muscarinic M3 bladder receptor, are being developed (e.g. 
darifenacin and varicamide). Imidafenacin is the latest antimuscarinic, but is marketed 
only in Japan and has been evaluated just in Assian populations [27]. Future studies 
with these antagonists will reveal whether or not the principle of selective M3 receptor 
antagonism offers therapeutic advantages. Since M3 receptors are not only located in the 
bladder, but also in the salivary glands and the intestine, this could mean that two of the 
most common side effects (dry mouth and constipation) will not be avoided. 
Since there is a lack of alternatives to antimuscarinics in the treatment of OAB symptoms, 
there has been an intensive search for new drug targets. Discovery of the b3-adrenoceptor 
with high expression in the bladder suggested that this receptor, which mediates detrusor 
relaxation, could be a target for overactive bladder symptom [28,29,30]. Several b3-
adrenoceptor agonists have been developed (e.g. isoprenaline,mirabegron). Available 
information suggests that β3-adrenoceptor agonists can be considered an attractive 
alternative to antimuscarinic for OAB treatment [31,32,33].  
8.3. Non pharmacological options
Activity in urinary reflex pathways can be influenced by activating nerves that synapse with 
this reflex system. This physiological process is called neuromodulation. Neuromodulation 
has been used by some investigators with success [34]. Peripheral electrical stimulation 
is thought to act through a mechanism involving reflex inhibition of motor output to the 
bladder and by activating inhibitory sympathetic fibres. Sacral, vaginal, anal, and lower 
extremity electrodes have produced ‘cure’ rates of as high as 20% and improvement rates 
as high as 50% to 60% [35]. 
Other therapies as bladder overdistention, transvaginal alcohol or phenol injections, 
and transvaginal  dissection, are forms of peripheral denervation or neurologic 
decentralization. Denervation is a misleading term because it is not a true denervation 
process. Denervation would be a technically difficult procedure because it is hard to 
destroy the parasympathetic fibres as they lie near or within the organs they innervate. 
Denervation therapies are associated with high relapse rates, up to 100% after 18 months 
[36].
Botulinum A toxin (Botox or Dysport), another new agent, blocks both afferent and 
efferent nerves when injected into the bladder wall. This causes a paralysis of the detrusor 
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that persists for several months. Botulinum A toxin is very well tolerated by patients and is 
a safe and impressive alternative [37]. No adverse events have been reported up till now. 
About 5% of the patients do not respond. Up to 90% of the responders will be completely 
continent and are able to stop or reduce the use of anticholinergics. However, the invasive 
procedure has to be repeated periodically. 
Auto-augmentation refers to a type of cystoplasty that involves excision of a large portion 
of detrusor  muscle with preservation of the underlying mucosa (detrusor myomectomy). 
This procedure allows a bladder diverticulum to form with consequent increase in capacity. 
However, such techniques are major surgical procedures with potential complications and 
it carries with it the risk of urinary retention.
8.4. Search for new pharmacological targets
Theoretically, OAB can be treated by pharmacological agents that decrease DO, decrease 
urgency and increase bladder capacity. Many drugs have been tried, but the results are often 
disappointing. Antimuscarinic agents, specifically M3 antagonists, were considered the 
‘gold standard’ of drug therapy in OAB. However, their associated side effects, particularly 
dry mouth, constipation and blurred vision can be prohibitive. β3-adrenoceptor agonists 
can be considered an attractive alternative for the treatment of OAB. However, adverse 
side affects such as dry mouth and gastrointestinal disturbances were also recorded using 
these selective therapeutic agents [31]. It seems that identification of new suitable targets 
for pharmacological intervention is a prerequisite to effectively treat OAB.
9. A shifted paradigm: focus on the bladder
It appears that attempts to explain the cause of the OAB have been primarily focused 
on abnormal expression of the micturition reflex, the so-called “neurogenic hypothesis”. 
However, evidence is accumulating that changes in the bladder occur, which may influence 
the outcome of nervous bladder control. For example, bladder outlet obstruction (BOO) 
due to benign prostatic enlargement (BPE) and OAB often occur together. Studies reported 
that nearly 50% of men with LUTS and urodynamically confirmed BOO had DO [38,39]. 
Interventions that target the prostate often leave a subset of patients with inadequate 
symptom control. It is shown that urgency, frequency and nocturia persist in 19% of men 
after TURP [40] and 83% of these patients experienced return of these symptoms at long-
term follow-up [41]. Interestingly, these complaints comprise LUTS during storage of urine 
in the bladder, which are the same symptoms as seen in the OAB. 
Furthermore, it has been shown that isolated strips of normal detrusor muscle contract 
spontaneously and widespread activity of the bladder wall has been found in bladders 
that have been disconnected from the nervous regulatory systems [42-46]. This activity 
is highly modified in specimens dissected from overactive bladder [47-49]. It is therefore 
plausible that the human bladder has an intrinsic substrate for developing DO which is in 
fact non neurogenic.
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10. Thesis outline and study rationale
The etiology of the overactive bladder (OAB) is still poorly understood. In chapter 2 we 
demonstrate the complexity of the syndrome by means of an example of the complex 
interplay between OAB and benign prostatic enlargement (BPE) in male Lower Urinary 
Tract Symptoms (LUTS). It seems that bladder outlet obstruction (BOO) plays a role in 
developing OAB. Focussing on nervous control of the lower urinary tract may therefore 
bring the false interpretation of considering the bladder as being a passive ‘black box’. 
Our study group started this project to disentangle the biochemical and structural changes 
occurring in the overactive detrusor. Our starting hypothesis is that the spontaneous 
pressure rises that occur in the overactive bladder are not neurogenic, but originate from 
non neuronal structures within the bladder wall itself. 
Chapter 3 presents an overview of the current hypotheses trying to explain detrusor 
overactivity (DO), in which the non-neurogenic theories will be emphasized. While 
doing so, the molecular basis for cell-cell crosstalk between diverse cell types within the 
bladder will be discussed.  
It seems that the human urinary bladder is a highly sophisticated organ, and much 
progress is made during the last decade in elucidating its cell biological and physiological 
characteristics. However, many questions remain and the molecular basis for cell-cell 
crosstalk between various cell types is yet an unelucidated mechanism. For instance, 
detrusor smooth muscle cells need to be mechanically coupled in order to obtain a 
functional syncytium. The physical interaction between cells in general is mediated by 
the filamentous cytoskeleton that is bridged from one cell to the other via membrane 
spanning cell adhesion molecules. The class of adhesion molecules that mediates physical 
interaction between cells of the same type are the cadherins. We hypothesize that a yet 
unknown member of the cadherin superfamily mediates the critical recognition signal 
and physical interaction between detrusor smooth muscle cells. We investigated the 
expression of multiple subtypes of the cadherin family in the human bladder. Chapter 4 
shows our results.
As mentioned previously, it seems that alteration in detrusor smooth muscle properties 
is a requisite for the production of the unstable pressure rises seen in OAB. During 
ultrastructural studies using Transmission Electron Microscopy (TEM), observations 
on detrusor smooth muscle cell arrangement, morphology and patterns revealed that 
the overactive detrusor has a distinctive ‘disjunction pattern’ compared to the normal 
bladder. It is characterized by widening of spaces between individual smooth muscle 
cells and reduction or loss of adhesive intermediate cell junctions. These changes are a 
common feature in all types of OAB, regardless of etiology. In chapter 5 we investigate 
the biochemical composition of intermediate junctions in normal and overactive 
human detrusor using immunohistochemical and electron microscopic techniques. We 
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hypothesize that cadherin-11 is downregulated in the disjunction pattern of the overactive 
detrusor.
During our former studies, expression of the subtype N-cadherin was found by coincidence. 
Its morphological appearance was highly interesting. It showed remarkable resemblance 
with expression profile of generally accepted histochemical markers for interstitial cells 
(IC). ICs are a recently discovered new type of cell within the bladder wall. In chapter 6 we 
used additional cell markers and electron microscopic techniques in an attempt to analyze 
our finding. We hypothesize that N-cadherin is a specific marker for interstitial cells in the 
human bladder.
The isolated bladder shows spontaneous non-neuronal contraction during the filling 
phase, also known as autonomous activity of the bladder. As frequency and urgency 
occur during this filling phase, detrusor overactivity can be seen as a consequence of 
exaggerated autonomous activity during the storage of urine. The interstitial cell is 
believed to play a potential role in coordination of this activity. In chapter 7 we investigate 
if N-cadherin positive cells could play a role in the etiology of the OAB. We hypothesize 
that the expression profile of the population of N-cadherin positive cells is altered in the 
overactive detrusor. 
In summary, our hypotheses are the following:
1) A yet unknown member of the cadherin superfamily mediates the critical 
recognition signal and physical interaction between detrusor smooth muscle 
cells.
2) Cadherin-11 is downregulated in the disjunction pattern of the overactive 
detrusor.
3) N-cadherin is a specific marker for interstitial cells in the human bladder.
4) The expression profile of the population of N-cadherin positive cells is altered in 
the overactive detrusor.
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Summary
We emphasize that male overactive bladder (OAB) symptoms are storage  lower urinary 
tract symptoms (LUTS). They may occur with or without bladder outlet obstruction (BOO), 
and are often found persistent after interventions targeted to the prostate. Because of the 
complex interplay between OAB and benign prostate enlargement (BPE) in male LUTS, we 
stress the necessity for measured evaluation and treatment regarding this interaction. In 
spite of concern about possible development of acute urinary retention (AUR) while using 
antimuscarinics, the first results of well-designed RCTs reveal that these agents (with 
or without an alpha-blocker) do not adversely affect urinary function and can be safely 
administered in men with LUTS.
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1. Voiding and storage LUTS
The prevalence of lower urinary tract symptoms (LUTS) in men is high. A large-scale multi 
national study revealed that 62,5% percent of men in the general population (n=5460) 
reported at least 1 lower urinary tract symptom [1].  LUTS include storage symptoms 
(daytime urinary frequency, nocturia, urgency, urinary incontinence) and voiding 
symptoms (slow stream, splitting or spraying, intermittency, hesitancy, straining, terminal 
dribble) [2]. Storage LUTS are reported nearly twice as often (51.4%) as voiding LUTS 
(25.7%). LUTS can be associated with pathological conditions of the prostate, the bladder, 
or both [3], in which benign prostatic hyperplasia (BPH) and the overactive bladder (OAB) 
play a major role. 
2. LUTS terminology: OAB and BPE
The overactive bladder (OAB) is characterized by urgency, frequency and nocturia with 
or without urge incontinence. In fact, it comprises the same symptoms as storage LUTS, 
but excludes types of incontinence other than urge incontinence. It therefore forms a 
comparable subset of storage LUTS as found being persistent after transurethral resection 
of the prostate. OAB is reasonably well correlated with detrusor overactivity (DO), which 
is defined as involuntary detrusor contractions during the filling phase, which the patient 
cannot inhibit.  
The term benign prostatic hyperplasia (BPH) is a term used and reserved for the typical 
histological pattern that defines the disease. Benign prostatic enlargement (BPE) is caused 
by BPH and may cause bladder outlet obstruction (BOO), a functional diagnosis.
3. The complex interplay of OAB and BPE
Because DO may be primary or develop secondary to BOO, as shown in obstructive animal 
models [4], a complex interplay of prostatic pathology and bladder dysfunction eventually 
leads to storage LUTS in men. However, one must keep in mind that existence of BOO and 
DO does not always have a causal relationship.  
The precise cause of DO in men with BOO has not been identified. It is suggested that BOO 
may cause DO by cholinergic denervation of the detrusor and consequent supersensitivity 
of muscarinic receptors [5]. BOO may also result in ischaemia, patchy denervation, altered 
electrical properties of smooth muscle and hypertrophied neurons. These changes lead 
to a re-organisation of the spinal micturition reflex, resulting in increased excitability 
and thereby triggering the sense of urgency and culminating in an involuntary detrusor 
contraction. This contraction clinically evokes storage LUTS.
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4. Evaluation of male LUTS
Initial evaluation of men with LUTS starts with completing a voiding diary, which provides 
accurate data of normal urinary habits. LUTS questionnaires, like the ICS male questionnaire 
or the IPSS questionnaire, estimates the patients subjective bother. Further analysis of 
male LUTS is primary targeted to the prostate. This is not surprising, as historically used 
terms to describe male LUTS were all focused on the prostate as main perpetrator (e.g. 
prostatism or clinical BPH). The urinary flow test, which measures peak urinary flow 
and residual volume, is used to evaluate bladder emptying. This uroflowmetry provides 
relatively reasonable correlation with bladder outlet obstruction (BOO), but may be 
misinterpreted by inaccurate detrusor contractility. In these cases, pressure-flow analysis 
is used to distinguish BOO from detrusor underactivity during voiding. 
However, many men with LUTS do not have BOO. Therefore, not all male LUTS can be 
screened in such a straightforward manner as previously described. Laniado et al. 
reported that urodynamically confirmed BOO occurred in only 48% of referred men with 
LUTS [6]. Additionally, BOO and OAB often occur together. Studies reported that nearly 
50% of men with LUTS and urodynamically confirmed BOO had DO [7,8]. This illustrates 
the core of complexity surrounding the diagnosis and treatment of male LUTS. Therefore, 
the ideal approach for evaluating men with LUTS, in whom presumptive therapy fails, is to 
always use full urodynamic analysis (cystometry for filling and pressure-flow for voiding) 
to identify possible underlying bladder pathology, like DO.
5. Rationale for pharmacological treatment
Contraction of the bladder involves stimulation of muscarinic receptors by acetylcholine, 
released from activated cholinergic nerves. However, muscarinic receptors mediate 
not only normal bladder contraction, but also the abnormal contractions in DO [9]. 
Muscarinic receptor antagonists (antimuscarinics) therefore serve as the cornerstone in 
pharmacological treatment of OAB.
BPE has both static (increased tissue mass) and dynamic (increased smooth muscle tone) 
components in the prostate [10]. Medical management using 5-alpha-reductase inhibitors 
(5-ARI’s) inhibits prostatic growth, whereas alpha-1-adrenergic receptor antagonists 
(alpha-blockers) reduce the tone of prostatic smooth muscle.
6. Treatment response in male LUTS varies
Practitioners should consider the possible involvement of bladder dysfunction in male 
LUTS, as interventions that target the prostate often leave a subset of patients with 
inadequate symptom control. It is shown that urgency, frequency and nocturia persist in 
19% of men after TURP [11]. Interestingly, this subset of storage LUTS comprises the same 
symptoms as OAB. Also, Thomas et al [12] have recently shown that even in men who 
have had resolution of OAB symptoms after TURP, 48 (83%) of 58 experienced return of 
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their storage symptoms at long-term follow-up (mean, 12.6 years after surgery). 
Lee et al [8] found that treatment response may vary in men with LUTS due to different 
conditions. After three months of treatment with doxazosin (alpha-blocker), 60 (79%) 
with BOO and 24 (35%) with BOO + DO reported symptomatic improvement. In those 
patients with no improvement, 32 of 44 (73%) with BOO + DO improved after combined 
therapy with tolterodine (antimuscarinic).
7. Undertreatment of  OAB in male LUTS
Despite equal prevalence of OAB, fewer men than women are treated with antimuscarinics. 
This can be explained by the alternatives in potential pathophysiology: male LUTS can be 
caused solely by bladder dysfunction or mixed with prostatic pathology. This results in a 
complex clinical presentation of OAB symptoms in combination with other LUTS (voiding 
symptoms) [13]. Also, significant regional and country differences in the definitions of 
LUTS and OAB often lead to confusing terminology. 
However, concerns about safety of treatment are most likely the major barrier to 
recognition of OAB symptoms in men with LUTS. Increased risk of acute urinary retention 
(AUR) after OAB treatment is still widely accepted.
8. Acute urinary retention 
Acute urinary retention (AUR) is a condition characterized by a sudden inability to 
urinate, which is usually extremely painful and requires catheterisation [14]. Although 
relatively uncommon, AUR can be a dramatic event for the patient. Population-based 
studies estimate the incidence of AUR in men to be approximately 0.2% to 0.7% per year 
[15,16,17]. Although the incidence of AUR is relatively low in the general male population, 
the risk for AUR increases with age. The incidence of AUR was 3 times higher in men aged 
60 to 69 and 8 times higher than in men aged 70 to 79 years, compared with younger men.
The causes developing AUR can be classified into three categories. The first relates to any 
event that increases resistance to the urinary flow [16]. Secondly, weakness of detrusor 
muscle or interruption of sensory innervations of the bladder wall may results in AUR. 
The third category relates to any situation that permits the bladder to overdistend (e.g. 
post-surgery or drugs) [17].
Placebo arms of ‘BPH- trials’ may provide potential predictors of AUR. Several baseline 
characteristics correlate with the risk for spontaneous AUR and AUR-related surgery, 
including PSA, prostate volume and voiding International Prostate Symptom Score (IPSS). 
In the absence of AUR, baseline filling and storage subscores can be used as predictors of 
BPH-related surgeries [18-20]. The cumulative incidence of AUR in the placebo arms of 
the specified controlled ‘BPH’ trials was 0.6% to 2.1% per year [21-26]. Men in the placebo 
arms of these controlled trials were followed up for 2-4 years.
Post-void residual (PVR) volume may be used as a potential predictor of treatment 
outcomes. Results from the Medical Therapy of Prostatic Symptoms (MTOPS) trial 
demonstrated that higher baseline PVR was associated with slightly greater risk for clinical 
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progression [20]. According to clinical evidence, AUR develops in patients with steady 
increases in PVR but not with stable PVR throughout. Therefore, dynamic changes in PVR 
may be important [20,27,28].
9.           Antimuscarinics and AUR
As antimuscarinics decrease detrusor contractility, administration of it theoretically 
elevates the risk for developing AUR. However, it is postulated that during voiding, massive 
release of acetylcholine occurs from parasympathetic nerves, displacing antimuscarinics 
via competitive binding, thus resulting in normal voiding [29]. It is suggested that, at 
therapeutic doses of antimuscarinics, there is no effect on normal voiding and no increased 
incidence of AUR [30]. 
10. Evidence on safety of antimuscarinics 
Abrams et al. performed a multi-national, 12-weeks during, double-blind study, 
investigating the safety and tolerability of tolterodine instand release (IR) in men (n=221) 
with BOO and DO proven by urodynamics [31]. Patients were given tolterodine IR 2mg 
or placebo. Tolterodine IR improved volume to first detrusor contraction (VFC) (+59 ml, 
95%) and maximum cystometric capacity (CMC) (+67 ml, 95%) significantly. Tolterodine 
did not adversely affect urinary function in men with OAB and BOO. Urinary flow rate 
was unaltered, and there was no evidence of clinically meaningful changes in voiding 
pressure. Tolterdine was well tolerated, suggesting it can safely be administered in men 
with BOO. 
In other studies, a subanalysis of male patients with OAB in tolterodine extended 
release (ER) proved that treatment with tolterodine was not associated with increased 
incidence of AUR [32,34]. The authors concluded that the available data might be 
considered promising and the use of anticholinergic drugs was demonstrated to be 
“quite safe”. However, considering therapy with an alpha-blocker in combination with 
an antimuscarinic, studies were methodological not sufficient to support the clinical 
use of this combination therapy. Therefore, well-designed, large, double blind, placebo-
controlled, long-term, randomized-controlled trials (RCT’s) were needed [34].
11. Well-designed RCTs
The TIMES study was performed to evaluate the efficacy and safety of an antimuscarinic, an 
alpha-blocker, or both in men with LUTS that include OAB symptoms [35]. In this 4-arm study, 
patients (n=879) were randomly assigned to receive placebo, tolterodine, tamsulosin, or 
both tolterodine and tamsulosin for 12 weeks. Tolterodine, administered with tamsulosin, 
was an efficacious treatment. Compared with placebo, patients experienced significant 
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reductions in urgency and frequency episodes. This led to significant improvements on 
the total international prostate symptom score. The incidence of AUR was low and in 
patients with PVR<200 ml and Qmax>5 ml/s, no increase of PVR or decrease of Qmax 
was found. Tolterodin or tamsulosin alone however, was not sufficient to show significant 
clinical efficacy. 
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Summary
The neurogenic theory suggests that detrusor overactivity occurs as a result of changes in 
the peripheral and central nervous system of the bladder. However, focussing on nervous 
control of the lower urinary tract may bring the false interpretation of considering the 
muscular end organ as being a passive ’black box’. It seems that alteration in the musculus 
detrusor is a requisite for the production of detrusor overactivity: bladders that have been 
disconnected from central nervous system show spontaneous activity. The origin of this 
pacemaking activity remains unelucidated. But there is a growing body of evidence that 
detrusor overactivity can be seen as a consequence of exaggerated autonomous activity. 
Although the smooth muscle cells constitute the majority of cells within the human 
bladder wall, other type cells may have important functions in coordinating spontaneous 
activity. The human bladder could be arranged into modules of detrusor muscle, mediated 
by an intramural myovesical plexus that consists of neurons and interstitial cells. If the 
myovesical plexus could communicate with a suburothelial layer of interstitial cells that 
act as a sensing layer for bladder volume, we might have a proper model for integrating 
urge bladder sensation and detrusor contractions. 
It is proposed that synchronization of the modules would be imposed by the central nervous 
system during normal voiding. However, detrusor overactivity might be the consequence 
of synchronization of the modules arising during the filling phase. As alterations to the 
intramural myovesical plexus are found in detrusor overactivity of any origin, this cellular 
system could play a main role in the disentanglement of the OAB syndrome. 
This is an exciting time for basic research considering the overactive human detrusor. 
Although the pathophysiological aspects of the human detrusor are becoming more and 
more clear, the interaction of detrusor smooth muscle cells, interstitial cells, neurones 
and the urothelium in the human bladder remains a highly interesting field for further 
research.
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1.  Introduction
Lower urinary tract symptoms can be categorized as storage, voiding and postmicturition 
symptoms. The most common problem with urine storage arises when the bladder fails 
to remain relaxed until an appropriate time for urination. This syndrome is called the 
overactive bladder (OAB). The OAB syndrome is defined as urgency, with or without 
incontinence, usually with frequency and nocturia [1]. The key symptom of the OAB is 
urgency. The disorder can arise in the presence of bladder outflow obstruction (BOO) and 
in people with neurological disease, but is idiopathic in many cases [2]. OAB symptoms are 
suggestive of urodynamically demonstrable detrusor overactivity (DO) during the filling 
phase. DO is a generic designation of involuntary detrusor contractions during bladder 
filling, which the patient cannot inhibit, commonly resulting in urge to void, leakage of 
urine (incontinence) or both [3]. 
The etiology of the OAB and DO is still poorly understood and pharmacological tools 
to control it remain relatively ineffective. This is due to the fact that the mechanism 
of bladder contractility is not elucidated. Attempts to explain the cause of DO have 
been primarily focused on abnormal expression of the micturition reflex, the so-called 
“neurogenic hypothesis” [4]. However, evidence is accumulating that the spontaneous 
rises in pressure occurring in the OAB, regardless of etiology, are in fact non-neurogenic. 
Other theories have therefore been proposed regarding the cause of DO.  
The objective of this review is to give an overview of the current hypotheses trying to 
explain DO, in which the non-neurogenic theories will be emphasized. While doing so, the 
molecular basis for cell-cell crosstalk between diverse cell types within the bladder will 
be discussed.
2.           Neurogenic bladder hypothesis
Normal voiding and storage is controlled by central and peripheral nervous systems [4]. 
The central pathways in the brain and spinal cord are organized as simple on-off switching 
circuits. The peripheral system consists of three sets of peripheral nerves: the pelvic 
nerves, the lumbar nerves and the pudendal nerves. These nerves contain both afferent 
(sensory) axons and efferent (motory) pathways. Under additional sympathetic and 
parasympathetic control, the central and peripheral nervous system control the bladder 
and urethra as a functional unit.
The neurogenic theory suggests that DO can occur as a result of changes in peripheral 
and central nervous system of the bladder, hereby disrupting the voluntary control of 
the micturition pathway and causing an abnormal expression of the micturition reflex. 
These reflexes closely resemble the so-called primitive voiding reflexes. They can be 
induced by damage to the inhibitory neuronal pathways or sensitization of peripheral 
afferent terminals in the bladder. Neurogenic DO is often found in patients who suffer 
from cerebrovascular events, brain tumors, multiple sclerosis, spinal cord lesion, diabetes 
mellitus and Parkinson’s disease. However, focussing on nervous control of the lower 
urinary tract may bring the false interpretation of considering the muscular end organ as 
being a passive “black box”.
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3.           Myogenic bladder hypothesis
The human bladder is all but a passive “black box”. Isolated strips of normal detrusor 
muscle contract spontaneously and widespread activity of the bladder wall has been 
shown in bladders that have been disconnected from central nervous system control [5-
9]. It seems that the human bladder has an intrinsic substrate within the bladder wall 
for developing this spontaneous activity, which is non-dependent of the nervous system. 
This activity is highly modified in detrusor strips dissected from overactive bladder, 
regardless the etiology [10-12]. The myogenic basis for detrusor overactivity suggests 
that denervation of the bladder wall alters the properties and structure of detrusor 
smooth muscle, leading to increased excitability and increased ability of activity to spread 
between detrusor smooth muscle cells, resulting in coordinated myogenic contractions of 
the entire detrusor muscle and highly modified spontaneous activity [13]. It seems that 
alteration in the musculus detrusor is a requisite for the production of DO.
4.           Tissue remodeling of the detrusor muscle
Neurogenic, obstructed and idiopathic overactive detrusors all show patchy changes in 
detrusor smooth muscle fascicle structure [14-18]. Bundles of smooth muscle loose their 
intrinsic nerves and become infiltrated by elastin (elastosis) and collagen (collagenosis). 
Such remodeled bundles can exist alongside normal bundles. It must be noted that 
as defects in the overactive detrusor are punctuate and normal and modified areas 
are present within the same analyzed specimen, this has important implications for 
experimental studies on the nature of DO. 
During ultrastructural studies using electron microscopy (EM), it was found that the 
overactive detrusor has a distinctive ‘disjunction pattern’ compared to the normal bladder 
[19-26]. Next to denervation, this pattern is characterized by (1) marked reduction or loss 
of adherens junctions (AJs) between detrusor smooth muscle cells, (2) widening of spaces 
between individual smooth muscle cells coexisting with collagenosis and elastosis, and (3) 
appearance of abnormal ultraclose abutments and protrusion junctions which are alien 
to the normal detrusor. The authors claimed that these changes are a common feature in 
all types of the overactive detrusor, regardless of etiology. Therefore, they proposed that 
EM could be used as a diagnostic tool for DO.
5.           Ultrastructural studies and diagnostics
Elbadawi et al. concluded that EM examination of detrusor biopsies could be used in 
diagnosis of DO, replacing time-consuming and costly urodynamic studies [27]. Tse et al. 
found that adherens junctions, protrusion junctions and ultraclose abutments were all 
present in both stable and overactive specimens. However, the authors concluded that 
EM could still be used as an adjunctive technique to diagnose DO by calculating the ratio 
of abnormal-to-normal junctions [28]. This finding is in contrast to other studies in which 
a specific relationship between ultrastructural detrusor smooth muscle features and DO 
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was not confirmed [29,30]. Holm et al. investigated 25 patients with BOO-DO using the 
protocol of Elbadawi’s group. They found that the only significant parameter in bladder 
function was elastosis. 
The characterization of smooth muscle cell junctions by EM has important limitations, as 
the difficulty remains in classifying and interpreting more rudimentary forms of various 
types of cell junctions. To overcome this problem, Carey et al. used vinculin as a structural 
protein associated with AJ’s to study the disjunction pattern in normal and overactive 
detrusor [31]. The authors found expression of vinculin virtually occupying the entire 
detrusor smooth muscle cell membrane. However, their analysis relied on separate 
standard transmission EM and immunohistochemistry techniques: immuno-gold labeling 
of vinculin was not included. Also, vinculin is known as a classical attachment protein 
involved in the indirect binding of intracellular actin filaments to fibronectin of the 
extracellular matrix. Kuijpers et al. showed that cadherin-11 is an integral and structural 
protein of the AJ, using immunogold EM techniques [32]. Cadherins are a superfamily 
of transmembrane glycoproteins, which participate in cell-cell recognition and adhesion 
[33,36]. Cadherin-11 mediated adherens junctions form the basis for physical coupling 
between individual smooth muscle cells and suburothelial myofibroblasts by anchoring 
cytoskeletal myofilaments to the cell membrane in two opposing cell surfaces [37]. 
Expression of cadherin-11 in normal detrusor did not differ from overactive detrusor. Also, 
regional variation of cadherin-11 was found, contradicting the homogenous nature of the 
disjunction pattern. Although the role for cadherin-11 in tissue remodeling of the overactive 
detrusor remains unelucidated, the authors hypothesized that loss of cadherin-11 is a 
potential trigger for widening of spaces between individual smooth muscle cells and the 
appearance of collagenosis. Brierly et al. also could not reproduce the ultrastructural 
changes in the pathological bladder as described by Elbadawi et al [38,39]. It is therefore 
surprising that Elbadawi et al. were able to report perfect agreement between urodynamics 
and ultrastructure. In conclusion, it seems that the application of ultrastructural analysis 
as a diagnostic tool for DO cannot replace conventional urodynamics.
6.           Electrical coupling in detrusor smooth muscle
Although the EM analysis as described by Elbadawi et al. does not seem reproducible, 
it shows interesting features such as the appearance of abnormal ultraclose abutments 
and protrusion junctions. This appearance of abnormal junctions seems to co-exist with 
an increased expression of connexin-45, a gap-junction associated protein [40-42]. Gap 
junctions are specialized regions of plasma membranes formed by unique channels, 
which provide sites of low resistance. By mediating calcium transport they are likely to 
play an important role in the transduction of electrical stimuli necessary for multicellular 
smooth muscle contraction [43]. Detrusor smooth muscle cells of the normal bladder 
are poorly electrically coupled compared to other smooth muscles [44,45]. However, the 
newly formed abnormal junctions might be identified as family like gap junctions, thereby 
increasing the level of functional connectivity between smooth muscle cells. According 
to the myogenic hypothesis, a local contraction occurring at a particular region within 
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the detrusor wall may easier spread to adjacent cells and hence generate multicellular 
contractile responses resulting in DO. Since loss of AJ’s is believed to restrict the main 
vehicle for mechanical syncytium in detrusor smooth muscle cells, it might be possible 
that the overactive detrusor tries to restore this syncytium by forming a new and highly 
developed electrical coupled multicellular network. However, gap junctions expressing 
connexins have never been found in a convincing matter between detrusor smooth 
muscle cells during immunogold EM studies. It therefore remains unknown whether the 
abnormal ultraclose abutments and protrusion junctions are in fact true functional gap 
junctions. In conclusion, neither the neurogenic nor the myogenic hypothesis fully explains 
the recognized clinical and experimental findings. Therefore, other ways of approaching 
the pathophysiology of DO must be sought.
7.           Autonomous bladder hypothesis
A third and recently proposed hypothesis underlines the coordinated waves of 
contractions of the musculus detrusor that has been disconnected from central nervous 
control. It shows that there are two distinct types of contractile activity in the bladder: 
micturition contraction and autonomous activity [46,47]. Micturition contraction is 
associated with voiding. However, the human bladder also reveals contractile activity 
during the filling phase of the micturition cycle. This is shown in detrusor preparations, 
in isolated denervated bladders of animals and in human bladders during ambulatory 
urodynamics [48-52]. This non-neurogenic spread of excitation is generated within the 
bladder wall and is called autonomous activity. It has first been described for over 120 
years now, but has regained new interest [49]. Autonomous activity can be described 
as localized propagating waves of contraction traveling through the bladder wall. The 
number of these localized propagating waves increases as bladder filling proceeds. As 
OAB symptoms occur during the filling phase, urge to void and DO could be seen as a 
consequence of exaggerated autonomous activity during the storage of urine [48,53].
8.           Modulation of autonomous activity
Isolated detrusor strips and whole bladder models are used to further explore the 
physiological mechanism of autonomous contraction [53-58]. In the resting isolated 
guinea pig bladder, autonomous activity involves waves of contraction and localized 
stretches of the bladder wall at multiple locations, resulting in minimal amplitude of 
intravesical pressure changes. One should note the resemblance with non-micturition 
activity as found in human ambulatory urodynamics [59]. This activity was found in 
approximately 70% of patient who did not suffer from OAB complaints.) These waves 
of contraction travel considerate distances. Therefore, like the myogenic hypothesis 
presumes, synchronous contraction of a large number of detrusor smooth muscle cells 
must be a prerequisite for the occurrence of these large waves. 
Intramural neurons and detrusor smooth muscle cells seem to be potential cellular 
candidates in explaining the nature of coordination of autonomous activity. The 
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bladder contains a highly developed intramural network of neuronal elements which 
could coordinate synchronous contraction. However, alterations to this system fail to 
explain autonomous contraction waves as denervated bladder strips show exaggerated 
autonomous activity [60,61]. Therefore, autonomous contraction waves are most likely 
mediated by non-neuronal structures.
Detrusor smooth muscle cells could play a role in coordination of autonomous activity: 
gap junctions activate adjacent smooth muscle cells to eventually generate a large-scale 
multicellular contraction [62]. However, detrusor smooth muscle cells are relatively poorly 
electrically coupled in normal bladder [44]. It seems that myogenic transmission can only 
travel relatively short distances. Furthermore, quantitative impedance measurements 
showed an increased intercellular resistance in detrusor smooth muscle cells of the OAB 
[62,63]. It is therefore highly unlikely that smooth muscle cells account for a pathway by 
which spontaneous activity might travel throughout the bladder wall. Additionally, the 
anatomical organization of detrusor smooth muscle cells does not seem to allow a direct 
coupling between adjacent areas of muscle: detrusor smooth muscle cells are typically 
arranged in bundles that form an interlocking basket-weave pattern [64]. An arrangement 
such as this does not give rise to many close connections between cells. Thus, within 
the attempt to elucidate the physiological mechanism of autonomous contraction, there 
must be another cellular player.
Gillespie et al. further analyzed the distinct types of bladder contraction. Nerve stimulation, 
direct application of muscarinic agonists and increase of intravesical volume all augmented 
autonomous activity [46,53]. However, the phasic contractions of autonomous activity 
induced by muscarinic agonists could not be inhibited by the neurotoxin tetrodotoxin, 
suggesting that these phasic contractions do not involve the classical neuromuscular 
junction. Muscarinic receptors are expressed by detrusor smooth muscle cells, but also 
by another class of suburothelial cells [65,66]. These suburothelial cells show structural 
similarities to smooth muscle cells and fibroblasts and are closely associated with afferent 
and efferent nerve endings. They express the adherence junctional protein cadherin-11 
[37] and the gap junctional protein connexin-43, probably forming a tight physical and 
electrical syncytium [67,68]. It has been is proposed that these suburothelial cells could 
function as a sensing network for bladder filling, firmly held together by adherence 
junctions and communicating via gap junctions. Possibly, they receive input from the 
urothelium and efferent nerve endings, modulating afferent bladder function.
These suburothelial cells have recently been identified as myofibroblasts and are also 
called interstitial cells (ICs). Initially, ICs were thought to represent a specialized type of 
neurons, but it is now concluded that ICs are a unique class of cells, with a clear structural 
definition, functional role and pathological potential [69]. ICs are also housed in the 
detrusor layer, located on the boundary of muscle bundles. Like in the suburothelial layer, 
they are closely associated with intramural neurons and ganglia [70,71,72]. The detrusor 
ICs seem to form an intramural network, in which possibly information is relayed from the 
neuronal plexus. Considering their morphological appearance, they could play a major 
role in the coordination of autonomous activity of the human bladder. 
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9.           Markers to characterize bladder interstitial cells
ICs are often referred to as myofibroblasts. However, there is no consensus about whether 
these are the same cells. Myofibroblasts are considered to be smooth-muscle-like 
fibroblasts. They are contractile and express cytoskeletal filaments as vimentin, smooth 
muscle actin, desmin and heavy chain myosin [73]. They are physically coupled to each 
other by cadherin-11 mediated adherence junctions [74]. They have a spindle like shaped 
morphology and abundant pericellular matrix. Ultrastructurally, the myofibroblast has a 
prominent rough endoplasmatic reticulum (RER), a golgi apparatus producing collagen 
granules, multiple mitochondria, myofilaments with dense plaques, adherence junctions, 
gap junctions and fibronexus junctions. The human bladder ICs differ from myofibroblasts 
as they lack expression of desmin and heavy chain myosin [75,76]. 
Recent studies have identified various surrogate markers for bladder ICs, such as 
expression of the stem cell receptor C-kit and cyclic guanosine mono-phosphate (cGMP) 
[77,78]. C-kit is not expressed by all types of ICs and it can be detected in other cell types 
[79,80]. cGMP is induced by ICs in the bladder but is also expressed by urothelial cells [78]. 
Recently, it was found that N-cadherin was specifically expressed at cells with branched 
cell bodies and multiple processes in the suburothelial lamina propria and detrusor 
layer [81]. According to the authors, further immunohistochemical phenotyping and 
ultrastructural characterization using Transmission Electron Microscopy (TEM) indicated 
that this N-cadherin+ cell population most probably embodies ICs and thus could play a 
role as a discriminatory marker for ICs in the human bladder. This new marker for ICs in 
the human bladder was a welcome finding, as neither C-kit, cGMP nor vimentin labelling 
seem to be ideal in all tissues of the urinary tract.  
Nonetheless, the specific immunophenotype of human ICs is still controversial as it seems 
that these cells represent a heterogeneous population. Although it is tempting to speculate 
that bladder ICs are indeed myofibroblasts, caution is needed before a more complete 
understanding of their morphological, ultrastructural and physiological characterisation is 
realized. In this review we have adopted the term interstitial cells for all myofibroblastic 
cells (non fibroblasts) in the human bladder wall.
10.           Bladder interstitial cells and autonomous activity
The exact function of the network of bladder ICs has not been described, but can be 
hypothesized from analogous cells located in the gut. In the human gastrointestinal 
tract, a highly developed network of specialized ICs of Cajal (ICCs) is found in which ICCs 
interconnect through gap junctions [82]. ICCs have been placed in a central position in the 
nerve to muscle signal transmission, receiving direct neuronal input and transferring it to 
the smooth muscle cells [83,84]. They hereby coordinate gut peristalsis. 
ICs of the human bladder share properties with the ICCs. However, they embody a different 
subtype than the ICCs [85,86,87]. As ICs are closely associated with intramural nerves they 
might, like the gut, form an integrative plexus with neuronal structures within the bladder 
wall. It is hypothesized that the bladder, like the gut, is arranged into modules [88]. 
Boek 17.indb   42 12-5-2014   21:37:27
43
Pathophysiological aspects of the musculus detrusor
3
Modules of the bladder are circumscribed areas of detrusor muscle that are active during 
the filling phase. They are controlled by an intramural network of neuronal structures and 
ICs, also called the myovesical plexus. In this plexus, intramural ganglia play an important 
role. Ganglia can be considered as neuronal stations that receive diverse inputs from 
their environment. They are thought to relay the incoming information to an excitatory or 
inhibitory output signal. Thus, the myovesical plexus could form an integrative functional 
module that receives excitatory and inhibitory neuronal inputs and is able to realize local 
contractions [89]. The network of ICs in the detrusor layer could therefore not only play 
a major role in coordination of autonomous activity, but in voiding contractions as well.
11.           Bladder pacemaking
In order to develop autonomous activity in the denervated bladder, the bladder also 
requires an intramural site for pacemaking. Several structures such as the urothelium, 
intramural neuronal structures, ICs and smooth muscle cells have been investigated for 
this feature.
The urothelium is no longer considered to be a passive membrane. It is regarded as an 
integrated element in bladder signaling, receiving and expressing neurotransmitters. 
Vanilloid and purinergic receptors, adenosine triphosphate (ATP), nitric oxide (NO) and 
acetylcholine play an important role in urothelial signaling mechanisms [90]. Although 
the urothelium seems to be an important player in the system of bladder function, the 
urothelium is not considered to play a pacemaking role [91].
In experiments using denervated detrusor strips and whole guinea pig bladders, the 
peripheral nervous system could still play a pacemaking role. As denervation in DO 
is patchy, intrinsic nerves running through the human bladder wall could partly be 
maintained. However, localized contractions were not affected by atropine and the 
neurotoxin tetrodotoxin, which block nerve conduction [46]. Therefore, it is highly unlikely 
that autonomous activity is generated by neural pacemaking. 
Recordings of spontaneous electrical activity in detrusor strips using intracellular 
microelectrodes demonstrated that action potentials often occur in bursts that trigger 
multicellular contractions [92,93,94]. ICs in the guinea pig are spontaneously active and 
react to muscarinic receptor stimulation with firing of Ca+ mediated bursts [95]. In the 
detrusor layer, ICs are also located at the boundary of smooth muscle bundles. From 
here, spontaneous calcium transients originate, suggesting that ICs may be crucial in 
generating spontaneous activity [77,95]. However, others found that these spontaneous 
calcium bursts occurred independently from calcium transients originating from smooth 
muscle cells, even when synchronous calcium waves swept across the muscle bundles 
[85,87]. Therefore, it was proposed that ICs in the human bladder are not pacemakers for 
autonomous activity and thus are not a simple analogy of ICCs as found in the gut. 
Other studies using microelectrodes and intercellular calcium imaging have demonstrated 
that isolated detrusor smooth muscle cells are capable of generating spontaneous 
action potentials which are almost identical to those recorded from intact preparations 
[96,97,98]. It was suggested that autonomous contractions in the human bladder are 
Boek 17.indb   43 12-5-2014   21:37:27
44
Chapter 3
initiated by specialized detrusor smooth muscle cells and transmitted by ICs throughout 
the rest of the bladder. 
In conclusion, the search for the cellular mechanism triggering autonomous activity is 
characterized by conflicting findings. It seems that the intramural cellular pacemaker that 
triggers autonomous activity remains unelucidated.
12.           Interstitial cells and detrusor overactivity
Synchronisation of activity between different modules, mediated by increased coupling of 
ICs, could lead to an inappropriate augmentation of autonomous activity and predispose 
for DO. It seems that the network of ICs in the obstructed bladder is highly proliferated, 
resulting in intense bridging of the suburothelial ICs and the ICs located within the detrusor 
layer [99,100,101]. If these ICs form a functionally linked network, signals generated in 
the urothelium could be transported through this system towards the detrusor smooth 
muscle cells, where they could result into exaggerated autonomous contraction. Evidence 
for such an urothelium derived excitation has been postulated in the bladder of the guinea 
pig and the rat [102,103]. It must be mentioned that the urothelium not only forms a 
high-resistance barrier to ion, solute and water flux, and pathogens, but also functions 
as an integral part of a sensory web which receives, amplifies, and transmits information 
about its external milieu [104].
Others have also found a correlation between upregulation of IC-like cells and exaggerated 
autonomous activity. The authors investigated idiopathic and neurogenic detrusor 
overactivity specimens [105]. Imatinib mesylate (Glivec; a specific C-kit receptor inhibitor) 
had an inhibitory effect on the overactive detrusor. As C-kit labeling showed significantly 
more IC-like cells in overactive human detrusor layer than in normal specimens, it 
seems highly likely that this inhibitory effect is due to the upregulation of detrusor ICs. 
Additionally, reduction of ICCs is found in syndromes with reduced autonomous activity of 
the gut, such as Hirschsprung’s disease and functional intestinal obstruction [106].
Although the exact role for ICs in bladder function has not yet been described, structural 
changes to the interstitial network might not only result in alterations to the distribution 
of this activity, but also to the level of intrinsic activity and its sensitivity to excitatory and 
inhibitory mediators. 
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ABSTRACT
Objectives: 
It has recently been found that detrusor smooth muscle cells and myofibroblasts are coupled 
via gap junctions. However, gap junctions cannot account for strong physical interaction 
between cells, which has prompted the search for intercellular adhesion molecules. 
Cadherin-11 is a candidate for such a molecule, since it mediates the interaction of dermal 
myofibroblasts in contractile wound granulation tissue. We therefore hypothesised that 
the physical adhesion between detrusor smooth muscle cells and myofibroblasts is 
mediated by cadherin-11. The aim of this study was to test this hypothesis.
Methods: 
Bladder biopsies from eight radical cystectomy specimens were snap-frozen, sectioned, 
and stained for E-cadherin; cadherin-11; a-catenin; b-catenin; g-catenin and smooth 
muscle cell/myofibroblast markers connexin-43, vimentin, desmin, smooth muscle actin, 
and smoothelin. Specimens were analysed by using binocular epifluorescent and confocal 
laser–scanning microscopy.
Results: 
Specific positive membranous expression of all adhesion complex molecules except 
E-cadherin was detected in detrusor suburothelial tissue. All biopsies showed a similar 
punctate pattern of expression for cadherin-11 within bundles of smooth muscle cells and 
a suburothelial layer of cells. Cadherin-11 was specifically located at the cell membrane, 
in distinct linear domains. 
Conclusions: 
To our knowledge this is the first time evidence has been provided for cadherin-mediated 
smooth muscle and suburothelial myofibroblast cell-cell interaction in the human bladder. 
Cadherin-11 most probably plays an important role in the intercellular physical coupling of
detrusor smooth muscle cells and also of myofibroblasts.
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1.  INTRODUCTION
In the last few years, considerable progress has been made in understanding the cellular 
basis of contraction of the detrusor muscle. In contrast to the thought that the detrusor 
muscle is solely a collection of independent contractile cells, each activated by separate 
neural inputs, evidence is now accumulating that the detrusor muscle should be regarded 
as a set of functional units of smooth muscle cells that act cooperatively. The recent finding 
that detrusor smooth muscle cells and myofibroblasts (a recently identified suburothelial 
layer of cells) are coupled via so-called gap junctions supports this theory [1,2]. Gap 
junctions are specialized regions of plasma membranes formed by unique channels, which 
provide sites of low resistance. By transmitting small molecules and electric currents 
between the intracellular compartments, they can be instrumental in activating adjacent 
smooth muscle cells. These functional connections are, therefore, thought to regulate 
coordinated and synchronised detrusor smooth muscle contraction [2].
However, muscle cells also need intact intercellular mechanical adhesion. Without this 
adhesion, muscle bundles will break into pieces if simultaneous excitation occurs. This 
phenomenon is shown in plakoglobin knockout experiments in which disintegration of 
adhesion junctions between cardiac myocytes results in premature death of the animal 
because the heart literally breaks when it starts pumping [3]. Gap junctions cannot 
account for the required adhesion between muscle cells. This finding has prompted the 
search for adhesion complexes between detrusor smooth muscle cells.
Recently, evidence was provided for the presence of cadherins in adhesion junctions in 
cardiac myocytes [4,5]. Cadherins seemed to be a prerequisite for the formation of gap 
junctions. Cadherins are a superfamily of transmembrane glycoproteins, which participate 
in cell-cell recognition and cell-cell adhesion [6]. They play a crucial role in embryogenesis, 
organogenesis, and differentiation of cells in general. Cell type–specific expression has 
been demonstrated in various organs. So far, evidence for expression of cadherins in 
the human detrusor is still lacking. The best-characterised member of the cadherins is 
E-cadherin [6,7]. It mechanically connects epithelial cells via their extracellular domains, 
forming membrane-bound adherens junctions (AJs). Intracellularly, the cytoplasmic tail 
is coupled to the actin filamental network via catenins. AJs are in fact anchoring points 
for the actin (microfilament) bundles of the cytoskeleton. The AJ typically mediates 
homotypic cell-cell interaction. A candidate cadherin for expression in smooth muscle 
cells is cadherin-11, a type II cadherin, since it was identified in dermal myofibroblasts in 
contractile wound granulation tissue. Moreover, Hinz and colleagues [8] have shown that 
myofibroblast contraction can be attenuated by cadherin-11 antibodies.
We therefore consider cadherin-11 a suitable candidate for mediation of homophilic cell-
cell adhesion between detrusor smooth muscle cells and myofibroblasts. In this study we 
report our results about the expression of several cadherins, catenins and cytoskeletal 
proteins in the normal human bladder. To our knowledge this is the first time that 
cadherins and catenins have been identified in suburothelial myofibroblasts and detrusor 
smooth muscle of the normal human bladder.
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2.  METHODS
2.1.  Patients
Bladder tissue was obtained from eight individuals in whom radical cystectomy was 
performed because of localized bladder cancer. Samples were dissected from tumour-
free bladder areas at least 3 cm distant from tumour zones. Mean patient age was 57 
yr (range: 51–72), four male and four female. Biopsies were all taken from the vesical 
dome at tumour-free bladder regions from functionally normal bladders. The local ethics 
committee approved the study and informed consent was obtained from all patients. 
Full-thickness tissue pieces were collected and placed for cryosectioning in a mould 
containing Tissue-Tek (4583; Sakura, Zoeterwoude, The Netherlands) and snap-frozen 
immediately in isopentane at -80˚C. Using haematoxylineosin staining techniques, tissue 
was analysed under a binocular microscope for the presence of intact urothelium and 
smooth muscle.
2.2.  Immunofluorescence
Sections of 4 mm of directly frozen specimens were prepared with the use of a cryostat 
and mounted on Super Frost Plus (Menzel-Gläser) slides. For cadherin and catenin staining 
(Table 1), the unfixed sections were immersed in 3% paraformaldehyde for 10 min. Cell 
membranes were permeabilised in 0.2% Triton X-100 for 5 min. For cytoskeletal protein, 
staining samples were fixed in acetone for 10 min and air dried at room temperature for 2 
h. Each step was separated by washing samples three times for 2 min in magnesium and 
calcium-containing phosphate-buffered saline (PBSExtra: 40 ml PBS, 960 ml demiwater, 
100 ml 1 mol/l MgCl2, 100 ml 1 mol/l CaCl2). After washing, sections were incubated for 1 
h with the use of primary antibodies diluted in PBS 1% bovine serum albumin. The optimal 
antibody dilution was chosen empirically. Sections again were washed three times in PBS-
Extra. Next, the sections were incubated with Alexa Fluor 488 goat antimouse antibody 
(A-11017; Molecular Probes, Eugene OR, USA) and Alexa Fluor 488 goat anti rabbit 
antibody (A-11070; Molecular Probes). The range of different fluorochromes was used to 
optimise clarity of visualisation against natural background fluorescence of the bladder 
tissue, which was mainly due to autofluorescent elastic fibres. Finally, treatment with 
DAPI (24653; Merck, Darmstadt, Germany) or propidiumiodide (P4170; Sigma-Aldrich, St 
Louis, MO, USA) was performed for staining of the nucleus. All sections were mounted 
in Dako Cytomation Fluorescent Mounting Medium (S3023; Dako Cytomation, Glostrup, 
Denmark) for analysis. Negative controls included omission of primary antibodies and 
incubation with PBS-Extra instead. Positive controls included urothelial layer (internal 
control) in all sections and prostate cancer specimens for cadherin-11 (external control).
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Table 1 - Primary antibodies used
2.3.  Analysis
Immunostained sections were examined by binocular epifluorescent (DFC FX; Leica) and 
confocal laser–scanning microscopy (TCS NT; Leica). Series of images were sequentially 
recorded for each channel to avoid signal crossover. To help interpret the fluorescent 
images, we also stained cryosections with haematoxylin-eosin for examination using 
standard bright field optics. Cadherin and catenin expression profiles were related to 
tissue morphology and cytoskeletal markers.
3.  RESULTS
3.1. Suburothelial myofibroblasts express adherens junction molecules and contain 
contractile stress fibres
In all bladder specimens four distinct layers could be discriminated: the urothelium, the 
suburothelium, the detrusor muscle, and the serosa. There was a clear demarcation 
between the detrusor muscle and the urothelium and suburothelium. The urothelium 
was four to five cell layers thick, whereas the suburothelium contained connective tissue, 
blood vessels, and nerves. 
In all eight biopsies, the suburothelial layer of cells showed similar positive expression of 
several adherens junction molecules (cadherin-11, a-catenin, b-catenin) and cytoskeletal 
proteins (actin, vimentin). The urothelium served as an internal positive control for the 
E-cadherin and catenin antibodies. For cadherin-11 however, which is not expressed in 
bladder urothelium, prostate cancer specimens were used as a positive control instead. 
No immunoreactions were detected in the negative controls in any bladder specimen, 
but background signal was caused by autofluorescent elastic tissue fibres (Fig. 1). Specific 
punctate expression of cadherin-11 protein was found in a band of interstitial cells located 
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Figure 1 – Expression of adherens junction molecules and cytoskeletal proteins in the urothelial and suburothelial 
layer. Specimen overview by haematoxylin-eosin stain showing multiple layers of flattened cells just below the 
urothelial lining (A). Note urothelium and underlying layer of flat myofibroblasts (arrows A). Note autofluorescent 
collagen fibres in negative control (insert B). Clear punctate expression of cadherin-11 (B), a-catenin (C), and 
b-catenin (D) was found in the flattened suburothelial cells. These cells also expressed smooth muscle actin (E), 
vimentin (F), and connexin-43 (data not shown). Arrow heads (C and D) show linear, nonpunctate structures, 
most probably embodying small neurones and vessels. Binocular epifluorescent microscopy, magnification x100.
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in the suburothelial zone running parallel with and adjacent to the urothelium (Fig. 1). 
Several layers of flattened cells could be distinguished within this area by haematoxylin-
eosin staining. Double labeling with and expression of connexin-43 and vimentin, which 
are considered markers for myofibroblasts [9] (Table 2), identified these flattened cells 
as suburothelial myofibroblasts. At the bladder wall side facing the intravesical lumen, 
cadherin-11 immunoreactivity in these cells was limited to the urothelial basement 
membrane. Urothelial cells showed no immunoreactivity for cadherin-11. On the 
submucosal side, the density of cadherin-11 labelling reduced progressively as the 
depth increased and eventually disappeared at the deeper located layer of collagenous 
tissue (Fig. 2). Similar to the pattern of expression of cadherin-11, prominent punctate 
immunoreactivity for b-catenin was found just proximal to the basement membrane that 
lines the urothelium. However, punctate a-catenin was less intensively expressed, and 
staining for E-cadherin and g-catenin was negative (data not shown). The suburothelial 
myofibroblasts expressed cytoplasmic filaments containing smooth muscle actin (Fig. 1), 
but appeared to be negative for desmin and smoothelin (data not shown). Actin filament 
bundles showed close association with the punctate cadherin-11 staining (Fig. 2). 
In addition to the above-described punctate expression of cadherin-11 and catenins, 
positive staining of these proteins was found as non punctate linear structures within 
the suburothelial layer (Fig. 1). These suburothelial structures most probably reflect 
small vessels and neurones situated within and just below the layer of suburothelial 
myofibroblasts, since they showed remarkable resemblance in immunoreactivity with 
larger neurons and vessels situated in the serosa.
Table 2 – Twelve fields per specimen were examined independently of clinical data using a semi 
quantitative scale: S, no staining; +/S, low staining; +, intermediate staining; ++, high staining 
(average score)
Boek 17.indb   57 12-5-2014   21:37:30
58
Chapter 4
Figure 2 – Costaining of cadherin-11 (green), smooth muscle actin (red), and nuclei (blue) in the urothelium and 
suburothelial layer. Arrow heads mark thin urothelial layer. Suburothelial myofibroblasts revealed  punctuate 
staining for cadherin-11. Punctate labelling disappeared at the layer of collagenous tissue, which was detected 
as green fibres due to autofluorescence (arrow bottom left). Insert shows enlargement of a few suburothelial 
myofibroblasts. Erratic expression of actin filaments seemed to associate with membrane-located cadherin-11.
Note the nucleus staining centrally in the cell. Binocular epifluorescent microscopy, magnification x400.
3.2. Detrusor smooth muscle cells and suburothelial myofibroblasts show similar 
expression of cadherin-11
In all eight specimens the overall appearance of smooth muscle bundles was uniform, 
showing no loosened fascicular structure or widening of intercellular spaces between 
individual smooth muscle cells (Fig. 3). Muscle bundles were embedded in a band 
of connective tissue with a relatively sparse vasculature. Smooth muscle cells showed 
sharply defined fluorescent spots of immunoreactivity for cadherin-11 and b-catenin (Fig. 
3) in all biopsies, leaving no gender-related differences. This staining pattern showed great 
similarity with the punctate immunofluorescent signals as found in the suburothelial 
myofibroblasts. Costaining for smooth muscle actin (using phalloidin), cadherin-11, and 
nuclei showed that cadherin-11 expression seemed to be localised at the boundaries of 
closely adjacent smooth muscle cells (Fig. 4). In addition, no cadherin-11 expression was 
found at smooth muscle bundle boundaries, their component fascicles and nonadjacent 
smooth muscle cells. Thus, expression of cadherin-11 seemed highly specific for homotypic 
detrusor smooth muscle cell-cell interaction. Detrusor smooth muscle cells did not show 
expression of E-cadherin or g-catenin (data not shown) and a-catenin (Fig. 3). 
Smoothelin was used as a smooth muscle-specific marker. All smooth muscle cells showed 
positive staining for cytoplasmic smoothelin, desmin (data not shown), and smooth 
muscle actin (Fig. 3). Smooth muscle cells showed no expression of vimentin. However, 
vimentin-positive cells were present between smooth muscle bundles, as well as in the 
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microseptae surrounding their component fascicles (data not shown), but not between 
individual smooth muscle cells. They most probably reflect fibroblasts delineating the 
boundary of muscle fascicles.
Figure 3 – Expression of adherens junction molecules and cytoskeletal proteins in detrusor smooth muscle 
cells. Specimen overview by haematoxylin-eosin stain showing no loosened fascicular structure or widening 
of intercellular spaces between individual smooth muscle cells (A). No immunoreactions were detected in 
negative controls (insert B). Detrusor smooth muscle cells expressed clear punctate staining of cadherin-11 (B) 
and b-catenin (D). ‘In-line’ expression reveals the spindle-like shape of smooth muscle cells. No expression of 
a-catenin was found (C). Smooth muscle cells expressed smoothelin (E) and smooth muscle actin (F). Binocular 
epifluorescent microscopy, magnification x100.
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Figure 4 – Costaining for smooth muscle actin with phalloidin (red), cadherin-11 (green), and nuclei (blue) in 
transverse sections (A) of detrusor smooth muscle bundles. Cadherin-11 expression seemed localised at the 
edges of cytoplasmatic phalloidin-positive protrusions, leaving the flat sides in between unoccupied. However, 
‘in-line’ expression of cadherin-11, as found using a longitudinal approach (B), showed a punctate pattern that 
occupied virtually the entire cell membrane. Like in the suburothelial myofibroblasts, cadherin-11 and actin 
stainings were closely associated. Binocular epifluorescent microscopy, magnification x400.
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3.3. Punctate expression of cadherin-11 demarcates detrusor smooth muscle cell 
membrane
The dotted cadherin-11 expression pattern was characterised by several dots ‘in line’ 
and seemed to be confined to the membrane. However, using epifluorescent microscopy 
we could not unambiguously show that cadherin-11 was solely membrane bound (Fig. 
4). Therefore, confocal laser–scanning microscopy was used to evaluate expression in 
one optical plane (Fig. 5). Costaining of cadherin-11 and popidiumiodide showed lack 
of expression for cadherin-11 within smooth muscle cell cytoplasm and nucleus. In fact, 
stainings constantly showed considerable gaps between immunoreactivity for cadherin-11 
and propidiumiodide (Fig. 4). Lined up, point-like expression of cadherin-11 seemed to be 
located at the cell membrane of detrusor smooth muscle cells.
4.  DISCUSSION
While the molecular basis for cell-cell communication between detrusor smooth muscle 
cells is getting more and more clear, the function of the suburothelial myofibroblasts 
remains unknown. Myofibroblasts are fibroblastic cells with certain characteristics 
of smooth muscle. They possibly act in a manner analogous to the interstitial cells of 
Cajal, which have a role in pacemaker activity and transmission of excitation in the gut 
[9–11]. Others have suggested that myofibroblasts have the capacity to form a functional 
syncytium and could act as a layer of mechanoreceptors [1,12]. However, no contacts with 
detrusor smooth muscle have been described [1,12]. 
It has recently been found that detrusor smooth muscle cells and suburothelial 
myofibroblasts show prominent expression of connexins [1,2], which are proteins that 
form so-called gap junctions. Gap junctions cannot account for the required strong 
adhesion between smooth muscle cells. This fact prompted us to search for a cell 
junction, responsible for strong physical interaction between detrusor smooth muscle 
cells. To molecularly characterise these junctional complexes, we used cadherin-11 as a 
lead molecule, since for many other cell types the cadherins play a pivotal role in these 
junctions that are critical for cell-cell interaction and coupling.
Figure 5 – Confocal image, showing double labelling 
of cadherin-11 (green) and propidiumjodide (red) for 
nuclei in a few detrusor smooth muscle cells. Cad-
herin-11 protein was expressed as large dots. Note 
lack of expression of cadherin-11 within smooth 
muscle cell cytoplasm and nucleus. Cadherin-11 sig-
nal seemed membranously located, describing an ‘in-
line’ configuration. Neighbouring cells lack nucleus 
staining, most likely because of decentral transection 
of these cells. Confocal epifluorescent microscopy, 
magnification x10,000.
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In this study detrusor smooth muscle cells and suburothelial myofibroblasts expressed 
cadherin-11 in a punctate pattern at their cell membrane, highly resembling expression 
of adherens junctions in contractile myofibroblasts as found by Hinz et al [8]. Cadherin-11 
was not expressed at smooth muscle bundle boundaries, their component fascicles, 
and nonadjacent smooth muscle cells. This proves that the cadherin-11 signal is indeed 
specific for the smooth muscle and myofibroblast cell-cell interaction. To our knowledge 
this is the first time evidence has been provided for cadherin mediated smooth muscle 
and suburothelial myofibroblast cell-cell interaction in the human bladder. This finding is 
in contrast to a previous report in which the authors concluded that cadherins are not part 
of the detrusor smooth muscle cell-cell adhesion complex [14]. They found no expression 
for cadherins, using a pan-cadherin antibody. Also, a-catenin, b-catenin, and g-catenin 
expression could not be detected in any detrusor smooth muscle compartment. Since the 
internal controls (i.e., urothelium) were positive, the authors concluded that cadherins 
were not expressed. In our study, we used a highly sensitive and specific antibody for 
one cadherin subtype (cadherin-11). We evaluated the specimens with high-resolution 
imaging techniques and were able to visualise a complex containing cadherin-11 and 
b-catenin within the detrusor smooth muscle cells and the suburothelial myofibroblasts. 
Although dissection of our specimens was performed distant from tumour sites, an 
influence of cancer on cadherin and catenin expression in our biopsies cannot be ruled 
out. However, the similar constant level of cadherin-11 expression, as shown in all biopsies, 
may indicate that it was unaffected by tumour-related factors.
Three-colour imaging with cadherin-11, phalloidin, and DAPI showed that the dotted 
expression of cadherin-11 seemed to be confined to the membrane. This confinement, 
however, could not be concluded indisputably from this staining because some smooth 
muscle cells seemed to express some cadherin-11 in their cytoplasmic compartment 
as well. Confocal imaging was used to reject out-of focus fluorescence and evade this 
problem, which resulted in a clean image showing that cadherin-11 is located at the cell 
membrane of detrusor smooth muscle cells.
b-Catenin expression was localised to cadherin-11 expression. In contrast, a-catenin was 
not detectable in smooth muscle cells. Literature shows that membraneously bound 
b-catenin forms a complex with a-catenin [4]. The absence of a-catenin expression, as 
found in this study, suggests that physical interaction between b-catenin and cytoskeletal 
actin in detrusor smooth muscle cells is mediated by a yet unknown isoform of a-catenin 
or another molecule with homologous function. Remarkably, a-catenin was expressed in 
the suburothelial layer.
It is generally accepted that actin is the predominant form of filaments within contractile 
cells. Interestingly, the intermediate filament composition of the suburothelial- and 
smooth muscle cells was different. Smooth muscle cells were positive for desmin, 
whereas the suburothelial myofibroblasts also expressed the intermediate filament 
protein vimentin. The filament composition may be associated with functional differences 
of these cells. For example, evidence is provided that vimentin-based cadherin adhesion 
complexes cooperate with the traditional actin-based complex to promote strong cell-
cell adhesion [15]. It remains to be further investigated which filament actually forms 
a physical association with the cadherin-11 complex within smooth muscle cells and 
myofibroblasts. 
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In this study, several components involved in chain-like cell-to-cell linkage were studied 
and were shown to be expressed within suburothelial myofibroblasts and smooth muscle 
cells, except a-catenin. Since cadherin-11 is considered to be an essential protein in 
cell-cell contact, we consider cadherin-11 an excellent candidate to further molecularly 
characterise the cell-cell junctions in myofibroblasts and detrusor smooth muscle cells. 
This finding confirms the hypothesis that both cell types (myofibroblasts as well as 
detrusor smooth muscle cells) have the capacity to form a physically functional network 
of numerous smooth muscle cells acting cooperatively.
In ultrastructural studies using electron microscopy, observations revealed that adherens 
junctions  predominate in normal detrusor smooth muscle cells [16] and myofibroblasts 
[17]. Adherens junctions anchor convergent cytoskeletal myofilaments to the cell 
membrane in two opposing cell surfaces [18] and are considered to facilitate mechanical 
coupling [19].
5.  CONCLUSIONS
To our knowledge this is the first report of prominent puntate cadherin-11 expression 
between detrusor smooth muscle cells and suburothelial myofibroblasts. Considering 
its cellular location we hypothesise that cadherin-11 can play an important role in the 
intercellular physical coupling of detrusor smooth muscle and suburothelial myofibroblasts. 
The linear punctate expression of cadherin-11 could in fact mark the predominating 
adherens junctions in normal detrusor smooth muscle and suburothelial myofibroblasts as 
identified during former ultrastructural studies. We have now met the basic requirement 
for evaluating the functional role of cadherin-11 in association with bladder function. 
Future research will focus on electron microscopic and immunochemical evaluation of 
possible changes in adherens junctions as seen in different bladder dysfunctions. This 
focus seems particularly important as evidence is accumulating that detrusor muscle 
alterations play a major role in determining lower urinary tract symptoms [25].
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ABSTRACT
Purpose: 
We investigated whether analysis of adherens junctions in human detrusor could be used 
as a diagnostic tool to determine detrusor overactivity.
Materials and methods: 
We characterized the protein composition of adherens junctions in the human bladder 
using cadherin-11 since our group previously found that cadherin-11 could be an 
integral structural protein of adherens junctions. We obtained a total of 46 biopsies from 
23 patients categorized into 4 groups, including 5 who were normal, and 6 each with 
neurogenic disease with detrusor overactivity, bladder outlet obstruction with detrusor 
overactivity and idiopathic detrusor overactivity. Specimens were processed to study 
cadherin-11 expression using combined immunohistochemical and immunogold electron 
microscopy techniques. Cadherin-11 expression was semiquantitatively analyzed and 
correlated to with muscle fascicle structure and collagen in the extracellular spaces.
Results: 
Immunogold labeling showed highly specific cadherin-11 expression at adherens 
junctions in detrusor smooth muscle cells. During immunohistochemical staining a wide 
variety of cadherin-11 expression and fascicle structure was found in the same specimen. 
No correlation was noted between detrusor overactivity and cadherin-11 expression. 
However, cadherin-11 seemed to be downregulated with intercellular space  widening 
and collagenosis. 
Conclusions: 
Cadherin-11 is an integral structural protein of the adherens junction. Defects in the 
overactive detrusor are highly punctate. Quantitative analysis of adherens junctions using 
biopsy cannot replace urodynamic evaluation as a predictor of detrusor overactivity in the 
human bladder.
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1.  INTRODUCTION
The etiology of the overactive bladder (OAB) and detrusor overactivity (DO) is still poorly 
understood. DO can arise in the presence of bladder outlet obstruction (BOO) and in 
individuals with neurological disease but it is idiopathic in many patients [1]. Evidence 
is accumulating that structural changes in detrusor smooth muscle are associated with 
the unstable pressure increases seen in the OAB. In ultrastructural studies using electron 
microscopy (EM) it was found that the overactive detrusor has a disjunction pattern 
that is not found in the  normal bladder [2–5]. It is characterized by adherens junction 
(AJ) loss, collagenosis and widening of spaces between individual smooth muscle cells. 
AJs  predominate in the normal detrusor [6]. They are believed to facilitate mechanical 
coupling between adjacent smooth muscle cells by anchoring cytoskeletal myofilaments 
to cell membranes [7]. Cadherins are a super family of transmembrane glycoproteins 
that mediate homotypic adhesion between cells [8] thus, regulating embryogenesis, 
organogenesis and differentiation of cells [9]. Our group recently reported that the human 
bladder expresses cadherin-11 at the surface of adjacent detrusor smooth muscle cells 
[10]. We hypothesized that cadherin- 11 has an important role in the intercellular physical 
coupling of detrusor smooth muscle cells and in fact could be an essential, integral protein 
of the AJ. The aim of this study was to prove our hypothesis and investigate whether 
analysis of cadherin- 11 expression could be used as a diagnostic tool to determine 
detrusor overactivity.
2.  METHODS
2.1.  Patients
This study was done in biopsies from 12 female and 11 male patients 47 to 68 years old 
(mean age 60) with OAB complaints or genuine stress incontinence. Two cold cup bladder 
biopsies were obtained per patient from the posterior bladder wall during cystoscopic 
procedures. The local ethics committee approved the study and informed consent was 
obtained from all patients. 
All patients underwent full urodynamic analysis and were categorized into 3 groups, 
including 2 males and 4 females with neurogenic disease and DO, 5 males and 1 
female with BOO and DO, and 1 male and 5 females with idiopathic DO. Three females 
and 2 males 53 to 75 years old (mean age 65.6) with stress urinary incontinence and 
urodynamically proven, nonoveractive detrusor served as controls. These patients did 
not have neurogenic disease or BOO and were undergoing check cystoscopy. Filling 
cystometry at 50 ml per minute in patients with OAB revealed DO in all with a median 
CBC of 203 ml (range 28 to 450). Median CBC in control bladders was 400 ml (range 205 to 
500). The CBC of 205 ml was caused by major stress incontinence. In all patients with OAB 
intravesical pressure increases during filling were due to DO since compliance was normal. 
Acontractile detrusors were not included in analysis.
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2.2.  Electron Microscopy
Three human bladder biopsies from cases urodynamically proven to be not OAB 
were processed for standard transmission EM and immunogold EM. Processing for 
transmission EM was done according to the standard protocol using Somogyi fixative [11]. 
For immunogold EM analysis of cadherin-11 a post-embedding immunohistochemical 
technique was applied on thin sections obtained from material embedded at low 
temperature in Lowicryl® HM20 resin according to a previously used protocol [12]. 
Ultrathin sections were photographed using a TEM 1010 electron microscope (JEOL, 
Peabody, Massachusetts). Immunogold labeling control studies were done in human 
heart and kidney tissue. 
During ultrathin sectioning specimens were alternately stained with toluidine blue and 
analyzed for intact urothelium and detrusor smooth muscle tissue using a standard 
binocular microscope under low magnification. We subsequently selected areas of 
detrusor smooth muscle cells for further analysis. 
2.3.  Immunohistochemistry
Bladder specimens were collected and placed in a mold containing Tissue-Tek®. They were 
snap frozen immediately in isopentane at -80˚C. Sections (4 µm) were prepared using a 
cryostat and mounted on Superfrost Plus® slides. Using hematoxylin and eosin staining 
tissue was analyzed for intact urothelium and smooth muscle. Immunohistochemical 
staining for cadherin-11, smoothelin and 4,6-diamidino-2-phenylindole was done as 
previously described by our group [10].
2.4.  Morphological Analysis
Obtaining bladder specimens by the cold cup biopsy method allows the smooth muscle 
detrusor layer to be penetrated to a maximum of 2 muscle bundles deep. Thus, a limited 
amount of detrusor tissue is available for analysis compared to that of full-thickness 
biopsy. Four muscle fascicles per biopsy were photographed. The elastic van Gieson stain 
was used in parallel to visualize smooth muscle cells and extracellular connective tissue. 
Immunohistochemical staining was semiquantitatively analyzed for smooth muscle fascicle 
structure, cadherin-11 expression and the presence of collagen in the extracellular spaces. 
Fascicle structure was divided into 3 types, including compact structure, intermediate 
segregation and severe segregation of smooth muscle cells. According to cadherin-11 
expression and collagen fiber presence each fascicle was semiquantitatively graded as 
features not present in any photographs (-), present in fewer than 0 to a third (+), present 
in a third to two-thirds (++) and present in two-thirds to entire fascicle (+++). 
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3.  RESULTS
3.1.  Cadherin-11 localized to AJs
General smooth muscle fascicle structure was organized as compact bundles, interspersed 
by fascicles with moderate cell-cell separation (Fig. 1). Smooth muscle cells showed a 
cylindrical cell profile with crenellated cell contours. The sarcoplasm was packed with 
evenly distributed myofilaments of uniform orientation and alignment. It contained 
evenly dispersed dense bodies that appeared as uniform cigar-shaped densities. 
In all specimens the cell membrane was almost completely covered with classic AJs and 
dense plaques to which myofilaments seemed attached. However, AJs were not found at 
all smooth muscle cells. Dense plaques were formed of a complementary pair of electron 
dense areas located at the membrane of adjacent smooth muscle cells. However, AJs 
consisted of a pair of electron dense structures with a much smaller intercellular distance. 
Figure 1 – Transmission EM shows detrusor 
smooth muscle in normal bladder. (A) compact 
fascicle with cylindrical to polygonal profile of 
closely packed detrusor smooth muscle cells. 
Note abundant, electron dense signal at smooth 
muscle membranes. Reduced from x3,850. (B) 
contiguous cells are adjoined by complementary 
electron dense areas at membrane (asterisk). 
Undulating cellular perimeters indicate incomplete 
cell relaxation. Reduced from x10,500. (C) enlarged 
view of adherens junction (asterisk) shows typical 
laminated symmetrical structure traveling over long 
distance of cell membrane. Reduced from x420,000.
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Their membranous lining was much longer and more symmetrical.
In all immunogold EM samples classic AJs and dense plaques were found. Cadherin-11 was 
specifically expressed in AJs in a complementary manner (Fig. 2). This finding emphasized 
the homophilic fashion of cadherin mediated adhesion behavior, that is cells cohere with 
other cells that express the same cadherin subtype. However, due to the combination 
of oblique sectioning of AJs and ultrathin processing of specimens not all AJs showed 
cadherin-11 expression in a complementary manner. Also, cadherin-11 was expressed 
alternately at the intracellular and extracellular domains. This can be explained by the fact 
that cadherins are repetitive transmembrane macromolecules that contain intracellular 
and extracellular domains. Dense plaques did not express cadherin-11. 
3.2.  Cadherin-11 Heterogeneous Expression
In the suburothelial layer cadherin-11 expression was found in a band of myofibroblast-like 
cells running parallel with and adjacent to the urothelium (data not shown). Fluorescence 
signal intensity showed comparable results among samples but penetration depth into 
the deeper lamina propria varied considerably in each specimen. 
In smooth muscle cells cadherin-11 was expressed as a dense punctate pattern that 
occupied virtually the entire cell membrane. No cadherin-11 expression was found at 
smooth muscle fascicle boundaries and nonadjacent smooth muscle cells (Fig. 3). In 
all specimens cadherin-11 expression showed wide variety between smooth muscle 
fascicles throughout all detrusor muscle layers. Variety of cadherin-11 expression was 
also found within smooth muscle fascicles since some fascicles expressed cadherin-11 
homogeneously, others expressed it heterogeneously and some did not express it at all 
(Fig. 3). Duplicate analysis revealed identical expression patterns. Variety of cadherin-11 
expression seemed less in normal specimens but generally cadherin-11 expression did not 
seem to differ between normal and overactive detrusors. 
3.3.  Normal and Overactive Detrusor Structure Regional Variation
In all biopsies overall appearance in fascicle structure was variable rather than uniform. 
Elastic von Gieson stain revealed that the area between widely separated cells consisted 
mostly of collagen and, thus, embodied actual extracellular matrix. Thus, in vitro 
separation of adjacent cells during semithin sectioning was kept to a minimum. Although 
severe segregation of smooth muscle cells was often found in obstructed specimens, we 
noted no significant difference between normal and overactive detrusor when considering 
fascicle structure.
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Figure 2 – Immuno-gold labeling 
for cadherin-11 in detrusor smooth 
muscle cells of normal bladder. (A) 
Thin section of detrusor smooth muscle 
tissue showing specific expression of 
cadherin-11. Immuno-gold particles 
adhere exclusively to complementary 
cell membrane areas with high electron 
density. Magnification 10500x. (B) 
Gold labelling is specifically associated 
with typical laminated, symmetrical 
structures, travelling over a long distance 
of the cell membrane, identified as 
classical adherens junctions. The 
complementary matter of cadherin-11 
expression emphasizes the homophilic 
fashion of cadherin-mediated adhesion 
behavior: cells cohere with other cells 
that express the same cadherin subtype. 
Cadherin-11 is expressed alternately 
at the intra- and extracellular domain. 
Magnification 84000x. (C) Numerous 
submembranous caveolae are found at 
the cell membrane, which are the likely 
site for the entry of action potentials. In 
general, gold particles are expressed in 
pairs. Magnification x84000.
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3.4.  Cadherin-11 Down-Regulated With Collagenosis
Abundant collagen fibers in the intercellular spaces were found in 5 specimens, including 
to a moderate degree in 2 neurogenic bladder specimens and to a severe degree in 3 
obstructed bladder specimens (Fig. 4). However, collagenosis varied highly between 
fascicles. Some fascicles showed high collagenosis but adjacent fascicles showed no 
collagenosis. Generally cadherin-11 expression seemed to be down-regulated in areas 
with collagenosis since no cadherin-11 expression was found in fascicles with widely 
separated smooth muscle cells and abundant interstitial collagen fibers. However, 
although some fascicles lacked expression of cadherin-11, this did not always seem to 
coexist with collagenosis and cell-cell separation.
Figure 3 – Immunofluorescent labeling for cadherin-11 
in normal and overactive detrusor. Costaining of 
cadherin-11 (green), smoothelin (red), and nuclei 
(blue). Cadherin-11 is expressed as a dense punctate 
pattern that virtually occupies the entire cell 
membrane. Expression profile is highly heterogeneous 
throughout the fascicles. All stable and overactive 
specimens show three variations of expression of 
cadherin-11. (A) Homogenous expression throughout 
entire fascicle, (B) Variety in expression: high 
expression at border of fascicle and lack of expression 
in centre of fascicle (see asterisk), (C) Fascicle showing 
no expression at all (see asterisk) is neighbored 
by a fascicle which highly expresses cadherin-11. 
Although cadherin-11 expression varied throughout 
the specimens, this did not always seem to coexist 
with cell-cell separation. Binocular epifluorescent 
microscopy, magnification x100.
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Figure 4 – Cadherin-11 and collagenosis in overactive detrusor. DO due 
to BOO. (A&D) cadherin-11 (green), (B&E) smoothelin (red), (C&F) merge. 
(A-C) Severe collagenosis (cigar shaped green background signal) and lack 
of cadherin-11 expression is found in the lower fascicle (∞). This is in 
contrast to the upper fascicle in which a lively expression of cadherin-11 
in combination of nearly no collagenosis is found. Upper longitudinal 
bundle and lower transverse bundle represent first and second layer of 
detrusor bundles in bladder wall. (D-F) Again severe collagenosis with 
no expression of cadherin-11. Note the ‘jigsaw puzzle’ of smooth muscle 
cell contours. Contortion and twisting of smooth muscle cell branches 
seems to coexist with intermingling of collagen fibrils. (G) Suburothelium 
expression of cadherin-11 served as positive internal control of specimen 
in D. Binocular epifluorescent microscopy, magnification x100.
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4.  DISCUSSION
Evidence is accumulating that structural changes in detrusor smooth muscle are associated 
with the production of the unstable pressure increases seen in the overactive bladder 
(OAB). Elbadawi et al found that the overactive detrusor has a distinctive disjunction 
pattern in which loss of adherens junctions (AJs) and increased intercellular distance have 
a pivotal role [2–5] The studies of Elbadawi et al [2,4–6] led to the proposition that it 
is possible to diagnose detrusor overactivity (DO) by analyzing detrusor ultrastructural 
characteristics. However, numerous attempts to reproduce their results failed [13–15]. 
These conflicting results may be explained by the fact that electron microscopy (EM) 
only relies on ultrastructure to characterize junctions. Thus, classification is less certain if 
rudimentary forms of these AJs are present. Therefore, a highly sensitive, specific marker 
is needed for functional AJs.
The human bladder expresses cadherin-11 at the surface of adjacent smooth muscle 
cells [10]. Cadherin-11 is believed to have an important role in the physical coupling 
of detrusor smooth muscle cells and could in fact mark AJs. To test this hypothesis we 
integrated cadherin-11 expression and AJ ultrastructure. Immunogold labeling revealed 
that caderin-11 is an integral structural protein of AJs. Dense plaques did not express 
cadherin-11 and showed a much wider intercellular gap. They could represent separated 
AJs or other rudimentary forms of junctions. 
Carey et al concluded that vinculin is a sensitive, specific marker for AJs in detrusor smooth 
muscle cells [14]. However, their study did not include the highly specific technique of 
immunogold labeling. Also, since vinculin is known as a classic attachment protein involved 
in the binding of intracellular actin filaments to fibronectin of the extracellular matrix, we 
question their conclusions. All specimens showed remarkable variation in cadherin-11 
expression in the detrusor layer. Some fascicles did not express cadherin-11 at all. We 
believe that this heterogeneous expression profile is not based on processing artifacts 
since duplicate analysis showed identical results. The finding that AJs were not expressed 
by all smooth muscle cells in standard EM supports our finding.
This study was done in a relatively small patient cohort. However, analysis was performed 
in duplicate with 2 biopsies obtained per patient. Also, the complementary matter in 
which standard EM, immuno-EM and immunohistochemical techniques were used 
created a highly sensitive, specific analysis tool that merged protein characterization and 
cellular morphology. 
Heterogeneous expression of cadherin-11 was also found in control specimens, which 
could be explained by the limitations of urodynamics. Alternatively it was suggested that 
sensory urgency is a precursor of DO and may simply be earlier in the spectrum of disease. 
However, no control patient complained of OAB symptoms.
Roosen et al described cadherin-11 expression in bladder biopsies of patients with DO [16]. 
They found no changed expression in the detrusor layer. However, they did not describe 
regional variations in cadherin-11 expression. Since we found major variety in cadherin-11 
expression, we believe that it is unfeasible to quantitatively analyze immunohistochemical 
staining for cadherin-11 expression in the human bladder.
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Morphological analysis does not determine tissue functionality. However, the cadherin 
family of proteins is not only considered an integral part of adhesion junctions but actually 
defines their presence [17]. Thus, cadherin-11 down-regulation most probably reflects 
a disintegration of the adhesion complex at the cell membrane, making cadherin-11 
a functional marker of AJs in the human detrusor. Restriction of this main vehicle 
for mechanical coupling between smooth muscle cells would allow widening of the 
intercellular space, as found in this study.
Loss of the cadherin-11 complex could also account for the appearance of collagenosis. 
Fibroblasts are well-known producers of extracellular collagen. However, previous 
studies showed that the smooth muscle cell is also capable of producing collagen under 
specific conditions [18]. Cadherins are important morphogenetic regulators that confer 
cellular phenotypes by modulating the expression of their target genes located in the cell 
nucleus [9]. Therefore, loss of cadherin mediated signaling could not only explain loss of 
intercellular adhesion and widening of the intracellular space but also may change the 
phenotype of detrusor smooth muscle into collagen producing cells.
Highly modified areas were found adjacent to apparently normal areas. Areas that 
appeared normal in DO specimens were indistinguishable from control tissue. Such focal 
changes were also found by other investigators [15,19]. It was hypothesized that these 
areas match the topography of detrusor modules with each controlled by dedicated 
integrative circuits, as in the gut [20].
Furthermore, it seems that normal bladders can include highly modified modules without 
becoming overactive. If we consider that modified detrusor areas with cadherin-11 
down-regulation and increased intercellular space behave pathologically, exceeding their 
number beyond a certain threshold may drive the bladder into becoming overactive. Loss 
of cadherin-11 could mark a point of no return in this pathological condition.
5.  CONCLUSIONS
Cadherin-11 is an integral structural protein of adherens junctions (AJs). Therefore, it 
can be used to classify the uncertain rudimentary forms of cell junctions described by 
ultrastructural analysis. However, defects in the overactive detrusor seem to be highly 
punctate, making it unfeasible to obtain representative images of cadherin-11 expression. 
Thus, we conclude that quantitative analysis of AJs using immunostaining cannot replace 
urodynamic evaluation as a predictor of detrusor overactivity (DO). However, better 
understanding of cadherin-11 could shed more light on detrusor function. Although to 
our knowledge the progression of events that transform normal bladder behavior into 
overactivity remains unelucidated, we hypothesize that loss of the cadherin-11 adhesion 
complex could be a potential trigger for widening the spaces between individual smooth 
muscle cells and collagenosis.
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ABSTRACT
Aims:
Interstitial cells, also called myofibroblasts, most probably play a major role in the 
pathogenesis of the overactive bladder. However, no specific phenotypic marker has 
been identified. We investigated whether N-cadherin could play a role as a discriminatory 
marker for interstitial cells in the human bladder. 
Methods:
Bladder biopsies (n = 16) were collected from macroscopically nonpathological locations 
during cystectomy which was performed because of bladder cancer. Tissue was analyzed 
for expression of N-cadherin. N-cadherin+ cells were phenotyped using antibodies against 
PGP9.5, smoothelin, vimentin, and C-kit. Findings were related to bladder tissue histology 
and ultrastructure of myofibroblastic cells. 
Results:
N-cadherin+/vimentin+ cells with branched cell bodies were found in the lamina 
propria and detrusor layer. They were closely associated with neurons and showed no 
colocalization of PGP9.5 or smoothelin. A second type of N-cadherin+ cells was found at 
the boundary of detrusor bundles and in the lamina propria. These cells colocalized C-kit. 
We assumed that N-cadherin+/vimentin+ cells are similar to the ultrastructurally defined 
myofibroblasts. 
Conclusions:
N-cadherin can play a role as a discriminatory marker for interstitial cells in the human 
bladder, as the interstitial compartment of the human bladder houses a population of 
cells from mesenchymal origin, immunopositive for N-cadherin, vimentin and C-kit.
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1.  INTRODUCTION
The human bladder shows spontaneous contractile activity during the filling phase of 
the micturition cycle [1]. As this activity is also found in bladders that are isolated from 
the central nervous system, it seems that it is generated within the bladder wall. The 
overactive bladder (OAB) syndrome is associated with complaints of frequency and 
urgency that typically occur during the filling phase [2,3]. Spontaneous contractile activity 
of the bladder may share characteristics with peristaltic activity in the gastrointestinal 
tract [4]. Specialized pacemaker cells of the gut, also known as interstitial cells of Cajal 
(ICCs), are thought to behave as pacemaker cells that transmit their electrical activity to 
the smooth muscle [5,6]. Interstitial cells (ICs) are also found in the human bladder [7,8]. 
These cells are located throughout the lamina propria and detrusor layer. It has been 
suggested that they form a network integrating signals and responses in the bladder wall 
between various types of cells. However, ICs have several subtypes based on morphological 
appearance and differential expression of markers, like myofibroblasts, making the search 
for their exact functional role in the human bladder a contentious subject.
Recent studies have identified various surrogate histochemical markers for ICs, such as 
the stem cell receptor C-kit and cyclic guanosine monophosphate (cGMP) [8]. However, 
the specific immunophenotype of ICs is still controversial. C-kit is not expressed by all 
types of ICs and it can also be detected in other cell types [9]. Additionally, many C-kit 
antibodies fail to detect ICs in positive control tissues. cGMP is a marker for ICs in the 
bladder but it is also expressed by urothelial cells [8]. Thus, so far, no marker has been 
identified that can be considered as a specific phenotypic marker for ICs in the human 
bladder. Therefore, irrefutable confirmation of the interstitial phenotype still depends on 
application of transmission electron microscopy (TEM), which is highly time consuming.
Cadherins constitute a superfamily of glycoproteins that participate in cell-cell recognition 
by functioning as signaling centers [10,11]. We have previously shown that cadherin-11 
is expressed by ICs in the lamina propria [12]. Cadherins may therefore play a role in 
regulating an intramural network of these cells. As subpopulations of bladder ICs exist, 
another subclass of cadherins might account for a specific discriminatory marker for 
interstitial cells in the interfascicular planes of the detrusor layer. N-cadherin is known 
to regulate mesenchymal cell development [13] and is the most commonly expressed 
cadherin in stromal cells [14,15]. We therefore investigated the expression of N-cadherin 
in the normal human bladder. We used additional immunohistochemical cell markers as 
well as transmission electron microscopy (TEM).
2.  MATERIAL AND METHODS
2.1.  Patients
Bladder biopsies (n=16) were collected from sixteen individuals in whom radical cystectomy 
was performed because of muscle invasive bladder cancer. Mean patient age was 62 years 
(52–75), nine males and seven females. Samples were dissected from tumour-free bladder 
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areas at least 3 cm distant from tumour zones. Biopsies were all taken from the vesical 
dome from functionally stable bladders. All of the patients underwent primary resection 
in terms of early cystectomy and none of the patients underwent intravesical installation. 
The local ethics committee approved the study and informed consent was obtained from 
all patients. Full thickness specimens were collected and placed in a mould containing 
Tissue-Tek (Sakura) for cryosectioning. Specimens were snap frozen in isopentane at 
–80°C. Tissue was checked for intact urothelium using a hematoxylin-eosin stain.
2.2.  Immunohistochemistry
Sections of 4 μm specimens were prepared using a cryostat and mounted on Super Frost 
Plus slides (Menzel-Gläser). The unfixed sections were immersed in 3% paraformaldehyde 
for ten minutes and stained for N-cadherin (M142 Takara; C2542 Clone GC-4 Sigma). 
Cell membranes were permeabilized in 0.2% Triton X-100 for 5 minutes. For cytoskeletal 
protein staining, samples were fixed in acetone for ten minutes and air dried at room 
temperature for 2 hours. Each step was separated by wash in magnesium and calcium 
containing PBS (PBS-Extra: 40 mL 25x PBS, 960 mL demi-water, 100 μL 1 M MgCl
2
, 100 μL 
1 M CaCl
2
). Sections were incubated for 1 hour using primary antibodies diluted in PBS 1% 
bovine serum albumin for blocking. Sections again were washed three times in PBS-Extra. 
Next, the sections were incubated with Alexa Fluor 488 (A-11017, A-11070 Molecular 
Probes) or Alexa Fluor 594 (A-20185, A-11032 Molecular Probes). Finally, treatment with 
DAPI (24653 Merck) was performed for staining the nuclei. All sections were mounted 
in Fluorescent Mounting Medium (S3023 Dako Cytomation). Negative controls included 
omission of primary antibodies. The following antibodies were used to further phenotype 
N-cadherin+ cells: PGP9.5 (a pan-neuronal marker) (7863-0504 AbD Serotec), smoothelin 
(specific marker for smooth muscle cells [16]) (R4A ab8969 Abcam), vimentin (marker 
for fibroblasts) (RV203 Eurogentec), and C-kit (CD117 DAKO). For the latter antibody, 
specimens of human jejunum were used as positive controls.
2.3.  Transmission Electron Microscopy
Sixteen human normal bladder biopsies were also processed for standard transmission 
electron microscopy (TEM). Processing for TEM was done according to the standard 
protocol using Somogyi fixative [17]. Ultrathin sections were photographed using a TEM 
1010 electron microscope (JEOL, Peabody, Massachusetts).
2.4.  Analysis 
Immunostained sections were examined by binocular epifluorescent microscopy (Leica 
DFC FX). Four times ten slides were analyzed per full-thickness specimen. Each set of ten 
slides was separated by approximately 5 mm of tissue. Cryosections were also stained 
with hematoxylin-eosin to interpret the fluorescent images. Morphology, phenotypic 
expression of above mentioned markers, and the ultrastructure of myofibroblastic cells 
were evaluated.
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3.  RESULTS
3.1.  N-cadherin expression in normal human bladder
Throughout the entire bladder wall, N-cadherin positive structures were found. These 
structures were located immediately below the urothelium, throughout the lamina propria 
and in the detrusor layer (Fig. 1). Counterstaining with DAPI showed that the N-cadherin+ 
structures embodied branched cells provided with multiple processes (Fig. 2). N-cadherin 
expression showed a punctate pattern distributed throughout the entire cell body.
Suburothelial N-cadherin+ cells had branched morphology with multiple processes that 
seemed to form a network. In the detrusor, N-cadherin+ cells were found at different 
levels. N-cadherin+ cells with stellate morphology were also located at the boundaries 
of smooth muscle bundles. They seemed to interact with elongated N-cadherin+ cells 
running in the interfascicular planes, continuing as slender N-cadherin+ processes 
between smooth muscle cells.
Figure 1 – N-cadherin+ structures in the normal bladder wall. (A–D) A punctate signal for N-cadherin (green) 
reveals numerous positive N-cadherin+ cells within the bladder wall. (A) N-cadherin+ cells with multiple 
processes in the lamina propria. (B) Closely associated N-cadherin+ cells at the boundary of smooth muscle 
bundles. Note large size and stellate morphology. (C) N-cadherin+ cells running between smooth muscle 
fascicles show elongated instead of stellate morphology and reveal lateral branches (arrow) running into the 
muscle fascicles. (D) Intrafascicular, slender elongated N-cadherin+ branches run in parallel with the smooth 
muscle bundles. Magnification ×400. Uro: urothelium; Det: detrusor muscles.
Boek 17.indb   85 12-5-2014   21:37:43
86
Chapter 6
Figure 2 – Double staining of N-cadherin with smoothelin and PGP9.5. (A–D) Costaining of N-cadherin (green) 
and smoothelin (red) in the bladder wall shows no colocalization. (A) Transversal and (B) longitudinal sections. (C) 
N-cadherin+ structures intermingle with smooth muscle cells in the region of the muscularis mucosae (asterisk) 
(D) Note the aggregation of multiple N-cadherin+ cells in the lamina propria (arrow). (E) PGP9.5 is expressed 
by a nerve trunk (red). (F) Aggregated N-cadherin+/PGP9.5− cells are closely associated with a ganglion region 
(asterisk). Ganglion coexpresses background signal of N-cadherin, resulting in orange bodies (arrowheads). Note 
high contrast to the punctate expression of N-cadherin in the N-cadherin+/PGP9.5− cells. DAPI (blue) for nuclei. 
Magnification ×400.
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3.2.  Phenotyping of N-cadherin positive cells
Staining for smoothelin confirmed that N-cadherin+ but smoothelin- cells were housed 
at the border of smooth muscle fascicles (Fig. 2). Inside the fascicles, they continued 
as elongated processes running in parallel with smooth muscle orientation spanning 
numerous smooth muscle cells. Irregularly arranged bundles of cells expressing smoothelin 
were found midway between the urothelium and the detrusor smooth muscle bundles. 
Those so-called muscularis mucosae varied considerably in diameter and formed a 
discontinuous layer of cells, densely surrounded and traversed by N-cadherin+ structures.
PGP9.5 immunoreactivity was found in both the lamina propria and detrusor layer. In 
the detrusor layer, primary nerve trunks run close to the detrusor bundles. Secondary 
neuronal structures were found in the connective tissue between smooth muscle fascicles, 
whereas smaller fibers run between small groups of smooth muscle cells. Double staining 
of N-cadherin and PGP9.5 showed no colocalization. However, close association between 
N-cadherin+ cells and PGP9.5+ neuronal structures was found (Fig. 2).
N-cadherin and vimentin were coexpressed by cells of ramified morphology in the 
suburothelial layer and deeper lamina propria (Fig. 3). These cells seemed to form a 
suburothelial network. However, many vimentin+ cells did not express N-cadherin. These 
N-cadherin−/vimentin+ cells showed different morphology. They were smaller and less 
elongated, had little perinuclear cytoplasm, and presumably embodied fibroblasts.
N-cadherin+/vimentin+ cells were also found at the border of detrusor smooth muscle 
bundles. Similar to the suburothelial region, these cells seemed to interconnect with 
each other, expanding into and throughout the smooth muscle fascicles like a network of 
N-cadherin+/vimentin+ processes.
The punctate pattern of N-cadherin expression was expressed throughout the entire cell 
body and at the cell membrane. In general, the small vimentin+ cells with little perinuclear 
cytoplasm did not express N-cadherin.
Most N-cadherin+ cells coexpressed vimentin. However, a second type of N-cadherin+ 
cells was found that did not coexpress vimentin. These cells were not housed between 
smooth muscle cells but were restricted to the edge of smooth muscle fascicles and were 
also found in the lamina propria (Fig. 3(f)). In contrast to the N-cadherin+/vimentin+ 
cells, these N-cadherin+/vimentin− cells showed different morphology: they had small 
appearance with little perinuclear cytoplasm sprouting into multiple cytoplasmatic 
processes.
3.3.  N-cadherin positive cells and interstitial cell marker C-kit
C-kit+ cells were found throughout the entire bladder wall (Figure 4). A large number 
of these cells coexpressed N-cadherin and showed similar morphology to the previously 
described N-cadherin+/vimentin− cells (Fig. 4(b)). They were located on the boundary of 
smooth muscle fascicles and in the lamina propria. Specimens of the human jejunum were 
used as a positive control for C-kit. The gut showed a large population of cells coexpressing 
N-cadherin and C-kit. Although most cells showed coexpression of N-cadherin and C-kit, 
N-cadherin+/C-kit− and N-cadherin−/C-kit+ cells were also found.
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Figure 3 – Double staining of N-cadherin and vimentin. (A) Two suburothelial cells coexpressing N-cadherin 
(green) and vimentin (red) are closely associated with each other (arrowhead). (B) Note punctate pattern 
of N-cadherin in contrast to the vimentin+ filaments, which both are expressed within the same cell body. 
Magnification ×1000. (C) Multiple elongated N-cadherin+/vimentin+ containing cells are closely associated at 
the border of detrusor smooth muscle bundles. Arrowheads show small vimentin+ cells with little perinuclear 
cytoplasm, highly resembling regular fibroblasts. (D) Detrusor fascicles show numerous N-cadherin+/vimentin+ 
processes (arrows) running between muscle cells. Magnification ×630. (E) Higher magnification shows expression 
of N-cadherin that is located at the cell membrane of some vimentin+ cells. Magnification ×1000. (F) Two cells 
localized at the edge of a smooth muscle fascicle. N-cadherin+/vimentin− cell is neighboured by a N-cadherin−/
vimentin+ cell. Magnification ×1000.
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3.4.  Ultrastructure of ICs in lamina propria and detrusor muscle 
In electron microscopy, interstitial cells with stellate morphology were found in the lamina 
propria and the musculus detrusor layer. They had characteristic features of myofibroblasts, 
such as cytoplasmatic filaments, focal densities and membranous attachment plaques, 
interrupted basal lamina of extracellular matrix, numerous mitochondria, and prominent 
rough endoplasmic reticulum (Fig. 5). From a morphological point of view, they appear to 
be similar to the N-cadherin+ cells as described in Figure 1.
Figure 4 – Double staining of N-cadherin and C-kit. 
(A) Arrows show cells in the bladder expressing C-kit 
(red). They lack expression of N-cadherin (green). 
Arrowhead shows a round cell with perinuclear 
expression of C-kit and diffuse cytoplasmic 
background signal for N-cadherin, highly resembling 
a mast cell. Elongated clusters of punctate 
N-cadherin+ cells lack expression of C-kit (asterisk). 
Magnification ×630. (B) Staining lacking DAPI for 
better orientation. Arrows show cells in the bladder 
expressing C-kit and punctate N-cadherin. These cells 
seem to give rise to N-cadherin+ branches (asterisk). 
Magnification ×1000. (C) N-cadherin+/C-kit+ cells 
running parallely (arrowheads) are neighboured by 
a slender elongated N-cadherin−/C-kit+ cell body 
(asterisk) and several smaller N-cadherin+/C-kit− 
cells (arrows) in the jejunum. Magnification ×630.
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Figure 5 – Ultrastructure of interstitial cells. (A) A myofibroblast located in the lamina propria. The cell is 
identified by filaments (fil), focal densities (fd), membranous attachment plaques (ap), subsurface vacuoles 
(arrow), mitochondria (m), and prominent rough endoplasmic reticulum (r). Cytoplasmic filaments cohere 
to a membranous attachment plaque, showing intimate association with its neighboring cell (arrowhead). 
Magnification ×420,000. (B) Overview of cells in the lamina propria. The left upper corner shows a myofibroblast 
(mf). Note its stellate morphology with multiple branches. The cell is accompanied by fibroblasts (f). Magnification 
×10,500. (C) Two closely associated interstitial cells in the detrusor layer. (D) Higher magnification of (C). 
Branched interstitial cell shows mitochondria (m), interrupted basal lamina (arrowhead), peripheral filaments 
(fil), membranous attachment plaques (ap), focal densities (fd), and prominent rough endoplasmic reticulum (r). 
Numerous tubulovesicular structures (open arrow) were found exclusively in this cell type.
4.  DISCUSSION
During the filling phase, the human bladder shows contractile activity which is generated 
within the bladder wall and does not result in intravesical pressure rise. It is also called 
autonomous activity [1–3]. It has been proposed that this activity shares characteristics 
with electrical rhythmicity in gastrointestinal muscles. Throughout the gastrointestinal 
tract, a network of interstitial cells of Cajal (ICCs) acts as pacemakers and conductors of 
electrical activity along the gut wall [5]. Initially, interstitial cells (ICs) were thought to 
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represent a specialized type of neurons, but it is now concluded that they are a unique 
class of cells [6]. As ICs are also found in the human bladder, it has been proposed that 
they mediate autonomous bladder activity [2].
Currently, ICs are identified by various surrogate phenotypic markers, but no 
immunophenotype has been identified that is fully characteristic for ICs in the human 
bladder [9]. Irrefutable confirmation of the interstitial phenotype depends on application 
of electron microscopy, which is highly time consuming. This study was performed in search 
of a specific marker for interstitial cells in the human bladder and electron microscopic 
investigations of the same biopsies had to confirm the immunohistochemical findings.
It has been suggested that ICs of the human bladder form a network of interacting cells [7,8]. 
Cadherin complexes participate in cell-cell recognition by functioning as signaling centers 
[10,11]. The subtype N-cadherin is known to regulate mesenchymal cell development [13]
and is the most commonly expressed cadherin in the interstitial compartment [14,15]. We 
therefore investigated the expression of N-cadherin in the human normal bladder.
N-cadherin+ cells were found in the lamina propria and the detrusor layer. They showed 
abundant punctuate expression of N-cadherin at their cell membrane and throughout 
their cell body. We cannot fully explain why N-cadherin was not exclusively expressed at 
the plasma membrane. However, other investigators also found that cadherins can be 
localized intracellular, rather than being characteristically concentrated at regions of cell-
cell contact [18].
Additional cell markers were used to further analyze our findings. Smoothelin is a smooth 
muscle cell specific marker [16]. As no colocalization of N-cadherin and smoothelin was 
found, we believe that the N-cadherin+ cells do not represent smooth muscle cells.
Vimentin is expressed by fibroblastic cells [9]. A large population of N-cadherin+ cells 
coexpressed vimentin. They showed elongated or stellate morphology with multiple 
processes that seemed to form a network. However, many vimentin+ cells did not express 
N-cadherin. These cells were smaller and less elongated, had little perinuclear cytoplasm 
compared to the N-cadherin+/vimentin+ cell, and appeared to be regular fibroblasts.
PGP9.5 was chosen as a pan-neuronal marker as it is generally accepted that this 
protein is expressed by all neuronal structures of the bladder wall [19]. No colocalization 
of N-cadherin+/vimentin+ cells and PGP9.5 was found. However, N-cadherin+ cells 
and PGP9.5+ neurons were closely associated. Furthermore, as mature neurons lack 
expression of vimentin [20], we believe that the N-cadherin+/vimentin+ cells do not 
represent neuronal structures.
C-kit is a widely used marker for ICCs of the gut [21]. We used specimens of the human 
gut as a positive control. ICCs of the gut coexpressed N-cadherin and C-kit. In the bladder, 
N-cadherin and C-kit were coexpressed by cells with little perinuclear cytoplasm seeming 
to sprout into N-cadherin+ processes. As these cells seemed highly similar to C-kit+ cells 
in human detrusor as found by others [22], we believe that they embody interstitial cells.
Interstitial cells are found in both the lamina propria and the detrusor layer of the 
human bladder. Myofibroblasts are a recently documented interstitial cell type housed 
in the interstitial compartment. They share characteristics with smooth muscle cells 
and fibroblasts. In a previous study, no ultrastructural evidence for myofibroblast 
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differentiation in the detrusor layer was discerned [23]. Interstitial cells within this layer 
were identified as fibroblasts. It is therefore generally believed that myofibroblasts 
in the human bladder solely refer to a specific group of interstitial cells within the 
suburothelial layer [24]. However, during our study, TEM revealed interstitial cells with 
stellate morphology in the lamina propria and the musculus detrusor layer. They had 
characteristic features of myofibroblasts. We previously showed that a suburothelial 
layer of cells expresses alpha smooth muscle actin myofilaments [12], most probably 
embodying the cytoplasmic filaments as shown during TEM in this study. Furthermore, 
fully differentiated myofibroblasts express alpha smooth muscle actin [25]. We therefore 
conclude that both the lamina propria and the detrusor layer house myofibroblasts, a 
unique class of interstitial cells.
From a morphological point of view, ultrastructurally defined myofibroblasts in the lamina 
propria and detrusor layer appear to be similar to the N-cadherin+/vimentin+ cells. 
Both techniques identified specified cells of mesenchymal origin with highly branched 
morphology and multiple processes that were closely associated with neighbouring 
homotypic cells.
This study shows a population of cells from mesenchymal origin with multiple phenotypes, 
immunopositive for N-cadherin, vimentin, and C-kit. These cells are housed in the 
interstitial compartment throughout the entire human bladder wall. The findings are 
in accordance with a recent study of Monaghan et al. in which multiple subgroups of 
vimentin+ cells with distinctive morphology were found in all layers of the bladder wall 
[26]. It is therefore likely that not all IC’s may be labeled with the same markers.
Heterogeneity of the interstitial compartment could be explained by a model in which 
C-kit and N-cadherin regulate mesenchymal cell differentiation. C-kit is an important stem 
cell marker used to identify certain types of progenitor cells [27]. Signaling through C-kit 
plays a role in cell differentiation, proliferation, and survival. The cadherins constitute a 
superfamily of glycoproteins that participate in cell-cell recognition [10]. Like C-kit, they 
play a crucial role in cellular differentiation and embryogenesis.
From a functional point of view, one should consider the following characteristics 
associated with the markers used. Similar to the gut, C-kit+ cells in the human bladder 
possibly act as pacemaker cells from which spontaneous calcium transients originate [28]. 
Cadherin complexes play a major role in cell-cell recognition and function as signaling 
centers [11]. Therefore, the population of N-cadherin+/vimentin+ cells may participate 
in specialized events such as spread of pacemaking activity. Although our results are 
promising, this study relies on morphological evidence. In order to illuminate functional 
properties of these cells, future research is needed using functional cell analyses, such as 
Ca-imaging and patch clamp techniques.
Although dissection of our specimens was performed distant from tumour sites, an 
influence of cancer cannot be ruled out. However, no thickening of the urothelial layer or 
abnormal urothelial morphology was found (Figure 6). Also, urothelium did not express 
N-cadherin, which is often seen in urothelial bladder cancer [29]. We therefore believe 
that our findings are unaffected by tumour-related factors.
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65.  CONCLUSIONS
This study shows that the interstitial compartment of the human bladder houses 
a heterogenous population of cells from mesenchymal origin, immunopositive for 
N-cadherin, vimentin, and C-kit. Due to characteristics associated with these proteins, 
this population of cells may participate in specialized events of the human bladder. We 
assume that N-cadherin/vimentin is a specific marker for a subpopulation of interstitial 
cells in the human bladder, that is, the ultrastructurally defined myofibroblasts. These 
cells may participate in spread of pacemaking activity. Although further insight is needed 
in the correlation between morphology and function of these cells, these findings could 
be promising in understanding normal and overactive bladder behaviour. Furthermore, 
we question the possible existence of one specific marker which defines the entire group 
of ICs in the human bladder.
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ABSTRACT
Objectives:
The human bladder shows spontaneous autonomous activity. Detrusor overactivity could 
be seen as a consequence of exaggerated autonomous activity. Interstitial cells (ICs) play 
a potential role in coordination of autonomous activity. As it is suggested that changes in 
ICs coexist with detrusor overactivity (DO), we investigated possible alterations to human 
bladder ICs. 
Methods:
Biopsies were obtained from 23 patients and were categorized into four groups: genuine 
stress incontinence (without DO) (n=5), neurogenic disease with DO (n=6), bladder outlet 
obstruction with DO (n=6), or idiopathic DO (n=6). Specimens were processed to investigate 
expression of N-cadherin and PGP9.5. N-cadherin expression was semiquantitatively 
analyzed and correlated to PG9.5 expression and bladder wall morphology. 
Results:
The population of cells expressing N-cadherin is altered in the overactive detrusor, making 
no difference between the sources of DO. Punctate distribution of morphological changes 
was found and downregulation of PGP9.5 expression seemed to coexist with upregulation 
of N-cadherin expression in the detrusor layer. 
Conclusions: 
The population of N-cadherin+ cells of the interstitial compartment of the human bladder 
has the ability to proliferate. As this proliferation seems to coexist with denervation, it 
could be possible that a highly developed network of interstitial cells replaces the loss of 
innervation in overactive detrusor.
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1.  INTRODUCTION 
The overactive bladder (OAB) is a symptomatic diagnosis based on the presence of 
urgency, with or without incontinence, and is usually accompanied by frequency and 
nocturia [1]. Its presence imposes a huge burden on the healthcare system, society, and 
affected individuals [2]. Patients with OAB symptoms and detrusor overactivity (DO) can 
be divided into three groups; those with neuropathic laesions, those with bladder outlet 
obstruction (BOO), and those with neither (idiopathic DO) [3].
Although relatively little is known about the aetiology of DO, it is now clear that the 
human urinary bladder cannot merely be seen as a passive ‘black box,’ solely controlled 
by neuronal input. Recently, it was found that the isolated bladder shows spontaneous 
nonneuronal contraction during the filling phase, also known as autonomous activity of 
the bladder [4]. As frequency and urgency occur during this filling phase, DO can be seen 
as a consequence of exaggerated autonomous activity during the storage of urine [5].
Two cell types play a potential role in coordination of autonomous activity: interstitial 
cells (ICs) and intramural neurons of the bladder wall. In the human gastrointestinal 
tract, specialized ICs of Cajal (ICCs) interconnect through gap junctions and function as 
pacemakers and conductors of electrical activity between enteric neurons and smooth 
muscle cells [6]. They hereby coordinate gut peristalsis. ICs are also found in the human 
bladder, albeit of a different subtypes than the ICs of Cajal [7,8]. In the bladder, ICs are 
immunoreactive for the stem cell receptor C-kit, the cytoskeletal filament vimentin, the gap 
junctional protein connexin-43, the second messenger cyclic guanosine monophosphate 
(cGMP), and N-cadherin [9–12]. They form a network in the suburothelial area and between 
the detrusor smooth muscle fascicles. Double labelling confocal microscopy experiments 
revealed that the ICs are positioned in proximity to nerves [9]. Recent reports have shown 
that the bladder ICs respond to application of neurotransmitters, firing calcium waves 
when stimulated by carbachol or ATP [9,13]. It can therefore be hypothesized that by 
consecutive interaction of ICs with smooth muscle cells, neuronal firing could consequently 
result in detrusor muscle activation. Although the exact role for ICs in bladder function has 
not yet been elucidated, it is highly likely that either quantitative or qualitative changes in 
bladder ICs coexist with DO. We therefore investigated possible alterations to the network 
of human bladder ICs in the overactive detrusor using N-cadherin. Additionally, we used 
PGP9.5 (Protein Gene Product 9.5) as a pan-neuronal marker as it is generally accepted 
that this protein is expressed by all neuronal structures of the bladder wall [14].
2.  METHODS
2.1.  Patients
This study was conducted on biopsies from 12 female and 11 male patients, aged 47 to 
68 years (mean 60 years), suffering from OAB complaints or genuine stress incontinence. 
Two cold cup bladder biopsies were obtained from each patient from the posterior 
bladder wall during cystoscopic procedures. The local ethics committee approved the 
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study and informed consent was obtained from all patients. All patients underwent full 
urodynamic analysis and were categorized into three groups: neurogenic disease with 
detrusor overactivity (DO) (n=6; 2 male, 4 female), bladder outlet obstruction (BOO) with 
DO (n=6; 5 male, 1 female), or idiopathic DO (n=6; 1 male, 5 female). Three females and 
two males aged 53 to 75 years (mean age 65.6 years) with stress urinary incontinence 
and urodynamically proven nonoveractive detrusor served as controls. These patients did 
not suffer from neurogenic disease or bladder outlet obstruction and were all undergoing 
check cystoscopy. Filling cystometry (50 mL/min) in patients with OAB all revealed DO 
with a median cystometric bladder capacity (CBC) of 203 mL (range from 28 to 450). The 
median CMC in control bladders was 400 mL (range from 205 to 500). The CMC of 205 mL 
was caused by major stress incontinence. In all patients suffering from OAB, intravesical 
pressure rises during filling were due to DO, as compliance was normal. Acontractile 
detrusors were not included.
2.2.  Immunohistochemistry
Bladder specimens were collected and placed in a mould containing Tissue-Tek (Sakura). 
They were snap-frozen immediately in isopentane at −80°C. Sections of 4 μm were 
prepared using a cryostat and mounted on Super Frost Plus (Menzel-Gläser) slides. 
Using haematoxylin-eosin staining techniques, tissue was analyzed for presence of intact 
urothelium and smooth muscle.
Immunohistochemical staining was performed as previously described by our group 
[12]. Antibodies against the following markers were used: N-cadherin (rabbit polyclonal 
antibody); (M142 Takara, mouse monoclonal antibody; C2542 Sigma Clone GC-4), 
smoothelin [15], and PGP9.5 (mouse monoclonal antibody 7863-0504; AbD Serotec). 
Antibodies against PGP9.5 were used as it is generally accepted that PGP9.5 is expressed 
by all neuronal structures of the bladder wall [14,16,17]. Negative controls included 
omission of primary antibodies and incubation with PBS-Extra instead. Positive controls 
included human prostate cancer specimens [18].
2.3.  Morphologic analysis
Immunohistochemical photomicrographs were analyzed semiquantitatively for PGP9.5+ 
nerve profiles and N-cadherin+ structures. As cold cup biopsies were used, a limited 
amount of detrusor smooth muscle was available for analysis compared to transmural 
biopsies. A maximum number of four smooth muscle fascicles per biopsy were 
photographed. Three slides per specimen were analyzed in duplo. Each set of ten slides 
was separated by approximately 1 mm of tissue. According to expression of N-cadherin 
and PGP9.5, each fascicle was semiquantitatively graded as follows: features not present 
in any photographs, 0; present 0–1/3, +; present in 1/3–2/3, ++; present in 2/3-entire 
fascicle, +++.
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3.  RESULTS
3.1.  N-cadherin+ ICs in control bladder
All bladder specimens contained the following three layers of tissue: urothelium, 
suburothelium, and detrusor. Because of the used cold cup biopsy method, the detrusor 
smooth muscle layer was penetrated to a maximum of two muscle bundles in depth. Full 
thickness biopsies of human bladder consist of three layers of smooth muscle bundles.
According to our previous study [12], N-cadherin positive structures were found 
throughout the entire bladder wall. They coexpressed vimentin (Fig. 1 and 2), but showed 
no coexpression of the pan-neuronal marker PGP9.5 (Fig. 3) or the smooth muscle specific 
marker smoothelin (data not shown). No immunoreactivity for N-cadherin was found in 
the urothelial layer (data not shown). N-Cadherin expression profile highly resembled 
punctate C-kit expression as found by others [16].
N-Cadherin+ cells were located immediately below the urothelium and extended 
throughout the suburothelial lamina propria into the detrusor layer. They showed a 
branched morphology with multiple processes that were closely associated (Fig. 1). In the 
detrusor layer, N-cadherin was expressed by cells housed at the border of smooth muscle 
bundles, perifascicular, and within smooth muscle fascicles (Fig. 2).
PGP9.5 was expressed in all control specimens. PGP9.5+ nerves were often closely 
associated with N-cadherin+ cells. In the detrusor layer; muscle fascicles were neighboured 
by primary nerve trunks housed in planes of connective tissue. Smaller nerve branches 
were found between detrusor fascicles, continuing as small fibers penetrating the fascicles.
Figure 1 - Suburothelial interstitial 
cells in control bladder. Multiple 
suburothelial cells with bizarre 
morphology and multiple proces-
ses coexpress a punctate signal 
for N-cadherin (green) and a fila-
mentous signal for vimentin (red). 
Nuclei stained with Dapi (blue). Two 
cells are closely associated with 
each other (arrow). Cells expres-
sing vimentin but lacking expression 
of N-cadherin embody fibroblasts 
(asterisk). Magnification X630. 
Binocular epifluorescent microscopy.
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Figure 4 – N-Cadherin positive strings at the border of detrusor bundles in overactive detrusor. N-Cadherin 
(green) double labeled with PGP9.5 (red) and counterstained with Dapi (blue). (A) Two fascicles are almost 
entirely surrounded by planes of N-cadherin cells (arrows). A large nerve trunk (arrowhead in A and B) is found 
in the perifascicular connective tissue. However, note lack of PGP9.5 expression in the upper fascicle. Instead, 
this fascicle shows a relatively high expression of N-cadherin (asterisk in A and B). Note green background signal 
in smooth muscle cells that was upgraded to facilitate tissue orientation. Magnification X100. (B) Magnification 
of white rectangle in (A). Slender strings consisting of numerous N-cadherin+ cells (arrow) are accompanied 
by multiple N-cadherin+ cells (#) in their connective tissue coat. Magnification X400. Binocular epifluorescent 
microscopy.
Figure 2 – Interstitial cells in the detrusor 
layer of control bladder. Cells coexpressing 
N-cadherin (green) and vimentin (red) as 
found in the detrusor layer. Nuclei stained 
with Dapi (blue). Note red background 
signal in smooth muscle cells that was 
upgraded to facilitate tissue orientation. 
Arrowheads show slender punctate N-cad-
herin expression embodying ICs located in 
the interfascicular clefts (indicated by dot-
ted orange lines). Slender intrafascicular IC-
structures (arrows) run in parallel with and 
between individual smooth muscle cells. 
Cells expressing vimentin but lacking ex-
pression of N-cadherin (asterisk) embody 
fibroblasts. Magnification X400. Binocular 
epifluorescent microscopy.
Figure 3 – N-Cadherin and PGP9.5. N-Cad-
herin (green) was double stained with pan-
neuronal PGP9.5 (red) and counterstained 
with Dapi (blue). N-Cadherin positive in-
terstitial cell (arrow) is neighboured by a 
PGP9.5 positive nerve ending (arrow head). 
Both cell types do not show coexpression 
of both markers. Cigar shaped background 
signal embody collagenous fibres. Enlarged 
from magnification X400. Binocular epiflu-
orescent microscopy.
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3.2.  Changes to the population of N-cadherin+ cells in the OAB
In all specimens, N-cadherin and PGP9.5 expression showed wide variety between 
smooth muscle fascicles throughout all detrusor muscle layers. In general, N-cadherin 
expression seemed upregulated in overactive detrusor specimens compared to control 
specimens, making no difference between the sources of DO (Table 1). In overactive 
detrusor specimens, changes to the network of N-cadherin+ cells were found at 
intrafascicular level, perifascicular level, and at the border of smooth muscle bundles. 
Detrusor smooth muscle bundles with upregulated expression of N-cadherin seemed 
surrounded by long N-cadherin positive planes (Fig. 4). These planes were built up from 
numerous cells expressing N-cadherin, had a slender morphology, and were housed in 
a thick layer of connective tissue. At the area in which the interfascicular cleft met the 
outside of the muscle bundle, the strings were thickened (Fig. 5) and seemed to give 
rise to N-cadherin+ processes running in the interfascicular connective tissue planes. 
Interfascicular N-cadherin+ processes seemed to junction to nodes (Fig. 6). These nodes 
were not only housed between fascicles, but also between smaller groups of smooth 
muscle cells. In control specimens, higher expression level of intrafascicular N-cadherin 
was found in some fascicles as well. However, large strings, interfascicular penetrating 
structures, and large intrafascicular nodes expressing N-cadherin were never found in 
control bladders.
The invasion of N-cadherin+ structures did not occur throughout the entire bladder wall 
but was solely found in smooth muscle bundles that were surrounded by long N-cadherin+ 
strings. Changes to the IC network were found at each level of depth of the bladder wall 
and were not restricted to the urothelial side or outer layer of detrusor muscle. However, 
cold cup biopsies do not enable analysis of full thickness bladder wall morphology. No clear 
differences between overactive and control specimens were found in the suburothelial 
N-cadherin+ network.
Figure 5 – N-Cadherin positive strings 
and interfascicular cells. N-Cadherin 
(green) double labeled with PGP9.5 
(red) and counterstained with Dapi 
(blue). Detrusor smooth muscle fascicles 
(Det) are demarcated by the dotted 
orange line. Note green background 
signal in smooth muscle cells that was 
upgraded to facilitate tissue orientation. 
N-Cadherin+ string closely associated 
to an adjacent detrusor smooth muscle 
fascicle. A cell expressing N-cadherin 
is housed within the interfascicular 
connective tissue plane (arrowhead). 
Note the close association of a PGP9.5+ 
nerve profile (#) with N-cadherin+ cells. 
PGP9.5 is not intrafascicularly expres-
sed. Magnification X400. Binocular 
epifluorescent microscopy.
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Figure 6 – Intrafascicular N-cadherin positive nodes in the overactive detrusor. N-Cadherin (green) double 
labeled with PGP9.5 (red) and counterstained with Dapi (blue). Note green background signal in smooth muscle 
cells that was upgraded to facilitate tissue orientation. Detrusor smooth muscle fascicles (Det) are demarcated 
by the dotted orange line. (A) At the region where interfascicular connective planes meet, N-cadherin+ cells seem 
to accumulate and form interfascicular nodes (#). Note high level of intrafascicular N-cadherin in combination 
with low level of PGP9.5 expression (arrow). Filamentous shaped autofluorescent signal embody collagenous 
fibres. (B) A small group of muscle cells (asterisk) seems to be separated from the main fascicle by a penetrating 
N-cadherin positive structure (arrow). Magnification X400. Binocular epifluorescent microscopy.
Figure 7 - N-Cadherin upregulation and PGP9.5 downregulation in smooth muscle bundles. N-Cadherin (green) 
was double labeled with PGP9.5 (red) and counterstained with Dapi. Note red background signal in smooth muscle 
cells that was upgraded to facilitate tissue orientation. Detrusor smooth muscle fascicles (Det) are demarcated 
by the dotted orange line. (A) Detrusor smooth muscle bundles in normal bladder show a dense PGP9.5 nerve 
profile in combination with a low level of N-cadherin expression. Arrow shows N-cadherin positive cell. (B) A 
muscle fascicle in NDO specimen with relatively low PGP9.5 expression (arrowheads) and a relatively high level of 
N-cadherin+ ICs (arrows). Magnification X630. (C) Cryosection of NDO specimen showing PGP9.5 negative muscle 
fascicles with high level of punctate N-cadherin expression. Note that PGP9.5+ nerve profiles in the interfascicular 
cleft closely associate with N-cadherin+ structures (arrow). (D) Smooth muscle fascicle with severely upregulated 
expression of N-cadherin. Note that the intensity of N-cadherin expressions seems higher than PGP9.5 expression 
in normal bladder as shown in (A). Magnification X400. Binocular epifluorescent microscopy.
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Table 1 - Semiquantitative analysis of intrafascicular N-cadherin and PGP9.5 expression in 
control and overactive detrusor.
3.3.  Smooth muscle denervation co-exists with upgrade of IC network
Intrafascicular expression of N-cadherin and PGP9.5 both were heterogeneously 
expressed and varied from low, to intermediate, and high level of expression (Fig. 7). In 
general, the degree of immunoreactivity for N-cadherin seemed correlated with the level 
of PGP9.5+ innervation profile. Low expression level of N-cadherin was found to coexist 
with a high level of PGP9.5+ innervation grade (Table 1). In other fascicles, intermediate 
level of N-cadherin+ structures coexisted with an intermediate level of PGP9.5 expression. 
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Smooth muscle fascicles with limited or no expression of PGP9.5+ nerve profiles showed 
intense expression of N-cadherin.
We observed that although PGP9.5+ denervation was found, PGP9.5+ structures were 
still found in the interfascicular cleft (Fig. 7(C)). Large PGP9.5+ nerve trunks located in 
connective tissue planes outside smooth muscle bundles seemed not downregulated in 
overactive detrusor specimens.
4.  DISCUSSION
Understanding the pathophysiological mechanism behind detrusor overactivity (DO) is a 
challenge, as the bladder wall has a complicated structure. While the molecular basis for 
cell-cell communication between urothelium, neurons, and detrusor smooth muscle cells 
is getting more and more clear, the exact function of interstitial cells in the human bladder 
remains unelucidated.
The human urinary bladder shows spontaneous localized and propagating contractions 
during the storage phase [5]. The bladder may share characteristics with peristaltic activity 
in the gastrointestinal tract [19,20]. In the gut, the myenteric plexus controls peristalsis. 
This plexus is embodied by the intramural neurons and interstitial cells of Cajal (ICCs) [6]. It 
has recently been proposed that the human bladder, like the gut, consists of modules that 
contract independently or synchronously with neighbouring modules [21]. Furthermore, 
the modules would be abnormally active and better coordinated in DO, compared to the 
normal bladder.
According to this hypothesis, two cell types play a potential role in coordination of 
autonomous activity in the bladder: interstitial cells (ICs) and intramural neurons. ICs of 
the bladder share properties of the ICCs [7,8]. However, they embody a different subtype 
than the ICCs [7,8]. In the human bladder, ICs are immunoreactive for the stem cell 
receptor C-kit, the cytoskeletal filament vimentin, the gap junctional protein connexin-43, 
the second messenger cyclic guanosine monophosphate (cGMP), and N-cadherin [9–12]. 
It is highly likely that they form a network in the suburothelial area and between the 
detrusor smooth muscle fascicles. Although the exact role for ICs in bladder function has 
not yet been described, it seem that either quantitative or qualitative changes in bladder 
ICs coexist with increased excitability in the OAB. We therefore investigated possible 
alterations to the network of human bladder ICs using N-cadherin.
In our study, all biopsies possessed a large population of N-cadherin+ cells. During 
previous studies we found that N-cadherin most probably can be used as a marker for 
a subpopulation of bladder ICs [12]. N-Cadherin+ ICs were located in the suburothelial 
lamina propria and the detrusor layer. In the lamina propria, they showed a bizarre 
morphology with multiple processes that seemed to form a network. In the detrusor, 
N-cadherin+ ICs were housed at the border of smooth muscle bundles, perifascicular, and 
within smooth muscle fascicles. Throughout the bladder wall, ICs expressing N-cadherin 
were closely associated with PGP9.5 positive neurons. Therefore, these cells could form a 
myovesical plexus as found in the human gut. Possibly, neuronal information is received in 
the larger ICs at the border of bundles and passed through the intermediate N-cadherin 
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positive structures to small groups of detrusor smooth muscle cells.
We found changes to the network of N-cadherin+ ICs in most overactive detrusor 
specimens. These specimens revealed a remarkable variation in N-cadherin expression 
between and even within detrusor fascicles. This heterogeneous expression profile 
of N-cadherin is not based on processing artefacts, as in duplo analysis showed exact 
corresponding pattern of expression.
In the overactive detrusor specimens, upregulation of N-cadherin expression was found at 
three levels according to anatomical degree, in terms of smooth muscle bundles (level 1), 
smooth muscle fascicles (level 2), and smooth muscle cells (level 3). It seemed as if large 
N-cadherin positive structures surrounding smooth muscle bundles were newly formed 
(level 1), continuing as interfascicular N-cadherin+ processes junctioning to nodes (level 2) 
and slender intrafascicular N-cadherin+ branches possibly interacting with smooth muscle 
cells forming small modules (level 3).
In fascicles with high expression of N-cadherin, PGP9.5 expression seemed severely 
downregulated. The intensity of integration of N-cadherin+ structures between smooth 
muscle cells shows remarkable resemblance with morphological profile of intrafascicular 
PGP9.5+ innervation in normal bladder, albeit that the N-cadherin+ network seems much 
more developed. It is generally accepted that PGP9.5 is a nonspecific neuronal marker as 
it is expressed by all neuronal structures of the human bladder wall [14,16,17]. Therefore, 
it seems that the smooth muscle fascicles lacking PGP9.5 expression are actually 
denervated. Other investigators also found denervation in overactive detrusor and it is 
believed to be a general feature of pathological fascicles in the overactive bladder [22–
24]. It could therefore be proposed that a highly developed network of ICs replaces the 
loss of innervation of detrusor smooth muscle fascicles in the overactive detrusor.
Kubota et al. claimed to have found an increased population of suburothelial ICs 
coexpressing C-kit and vimentin in the BOO-guinea-pig model [25]. However, a network 
of fibroblasts weakly expressing C-kit and vimentin is also present in the human detrusor 
layer. These cells do not have IC-like ultrastructure [26]. Therefore, the suburothelial C-kit 
positive cells as found by Kubota et al. might possibly embody fibroblasts instead of ICs.
De Jongh et al. found differences in the number and distribution of cGMP+ ICs in the 
bladders of guinea pigs with surgically induced bladder outflow obstruction [17]. 
Unlike us, they found alterations occurring in the suburothelial area. It is known that 
suburothelial ICs consist of distinct populations of cells [27]. It might very well be possible 
that N-cadherin+ ICs embody a subpopulation of ICs as identified by cGMP expression 
which is not upregulated in the overactive detrusor. Also, as their study was performed 
in guinea pigs, upregulation of N-cadherin+ ICs in the human bladder could be reserved 
to the detrusor layer, while the population of suburothelial N-cadherin+ ICs remains 
unaffected.
Others also found a correlation between upregulation of IC-like cells and exaggerated 
autonomous activity. Imatinib mesylate (Glivec; a specific C-kit receptor inhibitor) had 
an inhibitory effect on the overactive detrusor [28]. As C-kit labeling showed significantly 
more IC-like cells in overactive human detrusor than in normal specimens, it seems likely 
that this inhibitory effect is due to the upregulation of detrusor ICs. Also, reduction of ICCs 
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is seen in syndromes with reduced autonomous activity of the gut, such as Hirschsprung’s 
disease and functional intestinal obstruction [29].
Normal detrusor smooth muscle cells have poor electrical coupling [30]. Local contractions 
of groups of smooth muscle cells have been shown to occur in the normal bladder, but 
these did not lead to intravesical pressure rise [31]. Studies of the overactive detrusor 
ultrastructure demonstrated the existence of ultraclose abutments and protrusion 
junctions [32]. It was proposed that these might be the routes of spread of electrical 
activity in the overactive bladder. However, abnormally wide spread propagation of 
spontaneous activity could not only result from increased coupling between smooth 
muscle cells, but also from altered properties of the IC network. If we consider denervated 
fascicles with an upregulation of N-cadherin expression to be overactive, exceeding the 
number of overactive fascicles beyond a certain threshold might drive the bladder into 
behaving overactive. Also, as detrusor smooth muscle bundles house pacemaker cells [9], 
DO might not need the synchronized nerve-mediated smooth muscle excitation in order 
to develop.
5.  CONCLUSIONS
It seems that the network of N-cadherin positive ICs in human urinary bladder has 
the ability to proliferate. As upregulation of N-cadherin+ ICs was found to coexist with 
denervation, it could be proposed that a developed network of interstitial cells replaces the 
loss of innervation of detrusor smooth muscle fascicles in overactive detrusor. However, 
further study is needed to gain more insight into the role of this cellular mechanism and 
its possible role in exaggerated autonomous activity in the pathological bladder.
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The overactive bladder (OAB) syndrome is defined as a symptom complex that includes 
urinary urgency, with or without incontinence, usually with frequency and nocturia. It is 
a common disorder affecting the quality of life in huge numbers of people worldwide. 
OAB symptoms are suggestive of urodynamically demonstrable detrusor overactivity 
(DO). The ‘golden standard’ urodynamic investigation has its limitations in diagnosing 
OAB symptoms and more sensitive and specific diagnostic tools are desired. Also, new 
suitable targets for pharmacological intervention are necessary. In search of potential 
pharmacological targets one needs to understand more of the etiology of the overactive 
bladder. Attempts to explain the cause of OAB have been primarily focused on abnormal 
expression of the neuronal micturition reflex system (the neurogenic hypothesis). However, 
we hypothesize that focussing on nervous control of the lower urinary tract may bring the 
false interpretation of considering the muscular end organ as being a passive ‘black box’. 
Evidence is accumulating that DO originates from within the bladder wall itself, due to 
structural changes of the detrusor smooth muscle. Our study group started this project to 
disentangle the biochemical and structural changes occurring in the overactive detrusor. 
In chapter 1 an introduction, the study rationale and outline of this thesis is given. It 
describes the physiological aspects of the lower urinary tract and the traditional view of 
bladder wall anatomy. Terminology and definitions of normal lower urinary tract function 
and dysfunction are presented. We demonstrate the size of the problem called the OAB 
and discuss limitations in current diagnostic tools and therapies.
Chapter 2 describes the complexity of terminology, evaluation and treatment of lower 
urinary tract symptoms (LUTS). LUTS include storage and voiding symptoms. The 
OAB syndrome comprises the same symptoms as storage LUTS, but excludes types of 
incontinence other than urge incontinence. Storage LUTS often persist after transurethral 
resection of the prostate (TURP) in benign prostatic enlargement (BPE). This finding 
suggests that non neurogenic factors, such as bladder outlet obstruction (BOO), play a 
role in development of the OAB syndrome. However, the precise cuase of DO in BOO has 
not been identified. Also, it raises the question whether an intrinsic substrate within the 
bladder wall exists that is responsible for developing DO. 
In chapter 3 an overview is given of the current theories trying to explain DO. The 
neurogenic, myogenic and autonomous hypotheses are discussed. The neurogenic 
theory suggests that DO can occur as a result of changes in the peripheral and central 
nervous system of the bladder, hereby disrupting the voluntary control of the micturition 
pathway and causing an abnormal expression of the micturition reflex. The myogenic 
theory suggests that changes in properties and structure of detrusor smooth muscle 
occur. This would lead to increased excitability and increased ability of activity to spread 
between detrusor smooth muscle cells, resulting in highly modified spontaneous activity. 
The autonomous theory suggests that DO can be seen as a consequence of exaggerated 
autonomous activity during the storage of urine. To test these hypotheses, one needs to 
assess the integrative processes of the entire organ, starting with detailed microscopic 
investigation of the human bladder.
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In chapter 4 adhesion complexes between detrusor smooth muscle cells are described. In 
most smooth muscle tissue, smooth muscle cells are extensively connected both electrically 
and structurally to produce coordinated contractions. Connexins are expressed by smooth 
muscle cells. They are the subunits that form the so called gap junctions that are in fact 
responsible for the transport of small molecules, as well as, charged molecules, from one 
cell to the other. Gap junctions are likely to be crucial for the transduction of electric stimuli, 
hereby mediating cell-cell communication and cell-cell contraction. However, muscle 
cells also need intact intercellular mechanical adhesion. Without this adhesion, muscle 
bundles will break into pieces if simultaneous excitation occurs. Gap junctions cannot 
account for the required tensile strength between muscle cells. The class of molecules 
that mediates homophilic adhesion are the cadherins. We have therefore investigated 
the expression of multiple subtypes of the cadherin family in the normal human bladder. 
Bladder tissue was obtained from eight individuals in whom radical cystectomy was 
performed because of localized bladder cancer. The study showed punctate expression of 
cadherin-11 in the membranes of detrusor smooth muscle cells, but also in suburothelial 
myofibroblasts. Myofibroblasts are a recently documented interstitial cell (IC) type 
localized in the interstitial compartment. They share characteristics with smooth muscle 
cells and fibroblasts. In both cell types cadherin-11 expression was closely associated with 
intracellular actin filaments of the cytoskeleton. We have concluded that cadherin-11 
mediates the critical recognition signal and physical interaction between detrusor 
smooth muscle cells within a bundle but also between suburothelial myofibroblasts. The 
suburothelial myofibroblasts may need strong intercellular adhesion as it is suggested 
that they could act as a stretch sensor during bladder filling, resulting in the sensation of 
urge to void.
In chapter 5 we have investigated whether analysis of adherens junctions (AJs), or 
adhesive junctions, in human detrusor could be used as a diagnostic tool to determine 
detrusor overactivity. During former ultrastructural studies using electron microscopy 
(EM), it was found that the overactive detrusor has a distinctive ‘disjunction pattern’ 
compared to the normal bladder. This pattern is characterized by reduction or loss of 
AJs between detrusor smooth muscle cells and widening of spaces between individual 
smooth muscle cells coexisting with collagenosis. Specimens from 23 patients were 
investigated, categorized into 4 groups, including 5 who were normal, and 6 each with 
neurogenic disease with DO, bladder outlet obstruction with DO and idiopathic DO. Using 
an interplay of immunohistochemical and immunogold electron microscopic techniques, 
we showed that cadherin-11 is an integral structural protein of AJs between detrusor 
smooth muscle cells in the normal and overactive detrusor. In fact, the punctate expression 
of cadherin-11 marks AJs as identified during ultrastructural studies for the disjunction 
pattern. Cadherin-11 seemed to be down regulated with intercellular space widening and 
collagenosis. However, a heterogeneous expression pattern of cadherin-11 expression and 
fascicle structure was found in the same specimen. No correlation was noted between DO 
and cadherin-11 expression. We have concluded that quantitative analysis of AJs using 
immunostaining cannot replace urodynamic evaluation as a predictor of DO. 
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In chapter 6 we have investigated whether N-cadherin could play a role as a discriminatory 
marker for interstitial cells (ICs) in the human bladder. ICs, also referred to as myofibroblasts, 
most probably play a major role in the pathogenesis of the overactive bladder by forming a 
network integrating signals in the bladder wall between various types of cells. However, no 
marker has been identified that can be considered as a specific phenotypic marker for ICs 
in the human bladder. Cadherins function as signaling centers between cells. N-cadherin 
is the most commonly expressed cadherin in stromal cells. Sixteen bladder biopsies were 
collected from sixteen individuals in whom radical cystectomy was performed because 
of muscle invasive bladder cancer. Bladder specimens were processed using combined 
immunohistochemical and transmission electron microscopy techniques. The study 
showed N-cadherin positive cells with branched cell bodies and multiple processes which 
were localized in the suburothelial lamina propria and detrusor layer of the normal 
human bladder. They showed no co-localisation of pan-neuronal nor pan-smooth muscle 
markers. Transmission electron microscopy revealed ICs with stellate morphology in both 
the lamina propria and the musculus detrusor layer. They had characteristic features of 
myofibroblasts and appeared to be similar to the N-cadherin positive cells. It seemed 
that N-cadherin was not a specific marker for the entire population of ICs. But we have 
concluded that N-cadherin can be used as a specific marker for a subpopulation of ICs in 
the human bladder, i.e. the ultrastructurally defined myofibroblasts.
In chapter 7 possible alterations to the population of N-cadherin positive cells are 
discussed. The autonomous hypothesis suggests that DO can be seen as a consequence 
of exaggerated autonomous activity. Autonomous activity of the bladder is defined as 
spontaneous non micturition contractions of the bladder during normal filling. Localized 
propagating waves of contraction travel through the bladder wall. This activity is intrinsic 
to the bladder wall. Abnormally wide spreaded propagation of spontaneous activity could 
not only result from increased coupling between smooth muscle cells (the myogenic 
hypothesis), but also from altered properties of the IC network. Specimen from 23 patients 
were analyzed, categorized into 4 groups, including 5 who were normal, and 6 each with 
neurogenic disease with DO, bladder outlet obstruction with DO and idiopathic DO. The 
study showed that the expression profile of the population of cells expressing N-cadherin 
was altered in the overactive detrusor, making no difference between the source of DO. 
Also downregulation of PGP9.5 (a pan-neuronal marker) expression seemed to coexist 
with upregulation of N-cadherin expression in the detrusor layer. We have concluded 
that the population of N-cadherin positive cells in the human bladder has the ability to 
proliferate. Furthermore, we suggested that a highly developed network of ICs replaces 
the loss of innervation of detrusor smooth muscle cells in the overactive detrusor.
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Animal models
Analysis of bladder biopsies to study the etiology of the overactive bladder has its 
limitations. Availability of bladder specimens from healthy individuals with normal 
bladder function and without comorbidity is low. For this reason, a number of specimens 
in this thesis were collected from individuals in whom radical cystectomy was performed 
because of localized bladder cancer. Dissection was performed distant from tumour sites. 
We believe that our findings are unaffected by tumour-related factors as no thickening of 
the urothelial layer or abnormal urothelial morphology was found.  However, influence of 
cancer cannot completely be ruled out. Furthermore, the overactive bladder shows focal 
morphological changes, resulting in highly modified areas adjacent to apparently normal 
regions. These issues may have important implications for experiments on the etiology of 
overactivity that use bladder biopsies, isolated detrusor muscle strips or dissociated cells. 
Research focussing on animal models using whole bladder preparations could overcome 
these problems. However, one must keep in mind that the overactive bladder (OAB) 
syndrome is a clinical and symptomatic diagnosis, and animals cannot report symptoms. 
Also, there are differences in the regulation of bladder function between humans and 
animal species.
Cadherin-11 as morphogenetic regulator
A-δ nerve fibers are the ones that have control in normal situations. Bladder contractions 
occur by activation of M2- and M3- muscarinic receptors by acetylcholine. In normal 
subjects the M3 receptor is most active, whereas in denervated bladders an increased 
expression of M2 receptors is seen. In pathological situations C-fibers appear to play a 
more pronounced role. Herein, the purinergic and vanilloid receptors are considered 
as suitable drugable targets. Cadherins are important morphogenetic regulators that 
confer cellular phenotypes by modulating the expression of their target genes located 
in the cell nucleus. It is now well established that loss and gain of cadherin function has 
profound cell biological consequences, such as change of cellular phenotype. Therefore, 
impaired function of the critical intercellular cadherin-11 mediated adhesion mechanism, 
as found in chapter 5, could account for dedifferentiation of the smooth muscle cell and 
explain switch in subtype expression and expression pattern of adrenergic/muscarinic/
purigenergic and or vanilloid receptors. 
Highly modified detrusor fascicles were found adjacent to apparently normal areas. 
Other investigators hypothesized that these areas match the topography of detrusor 
modules with each controlled by dedicated integrative circuits, as in the gut. It seems 
that normal bladders can include highly modified modules without becoming overactive. 
If we consider that modified detrusor areas with cadherin-11 down-regulation behave 
pathologically, exceeding their number beyond a certain threshold may drive the bladder 
into becoming overactive. Loss of cadherin-11 could mark a point of no return in this 
pathological condition. Further research is needed to gain further insight in this matter.
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Identification of interstitial cells
Interstitial cells (ICs) have several populations that can be discriminated by morphological 
appearance and differential expression of markers. This makes the search for their 
exact functional role in the human bladder a contentious subject. Various surrogate 
histochemical markers are available for ICs, such as the stem cell receptor C-kit and cyclic 
guanosine mono-phosphate (cGMP). In this thesis, we have concluded that N-cadherin 
could be used as a specific marker for a subpopulation of ICs in the human bladder. 
However, the specific immunophenotype of ICs is still controversial. Future research 
should focus on identification of the interstitial phenotype using above mentioned markers 
in combined electron microscopy and immunostaining techniques, e.g. immunogold 
electron microscopy. This would create a highly sensitive and specific analysis tool that 
merges protein characterization and cellular ultrastructure.
Cell-cell communication in interstitial cells
Denervation of the bladder wall is believed to be a general feature of the overactive 
bladder. In chapter 7 we showed that the interstitial population of cells has the ability to 
proliferate. If a highly developed network of interstitial cells replaces the loss of innervation, 
this could lead to increased ability of activity to spread between smooth muscle cells 
and increased excitability of the detrusor muscle. However, it remains to be investigated 
whether the interstitial cells function as an intercellular communicating network. In order 
to elucidate functional properties of these cells, more research is needed using functional 
cell analyses, such as Ca-imaging and patch clamp techniques.
Final remarks
The relatively new field of translational research of the overactive bladder is exciting 
and much progress is made during the last decade in elucidating its cell biological and 
physiological characteristics. However, many questions remain. Several hypotheses 
have been proposed trying to explain the cause of detrusor overactivity. In conclusion, 
neither the neurogenic nor the myogenic hypothesis fully explains the recognized clinical 
and experimental findings. The recently proposed autonomous theory however, is very 
promising. DO could be seen as a consequence of exaggerated autonomous activity 
during the storage of urine.
Although our group mainly focused on the detrusor layer, other areas in the human bladder 
could also play an important role in modulating urgency and detrusor overactivity. It is 
becoming more and more clear that the urothelium is more than a barrier that seperates 
urine from extracellular fluid. It also has sensory properties and is thought to serve as a 
mechano-sensor [1]. Urothelium releases several substances in response to physical and 
chemical stimulation [2]. Furthermore, it is has been shown that the lamina propria is 
heavily innervated [3,4]. It is suggested that the urothelium can control activity in afferent 
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nerves [5]. Therefore, the urothelium and lamina propria are considered as important 
regulatory parts of the bladder wall. This so-called urothelium based hypothesis may 
account for possible targets for therapeutic agents. 
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De nieren zijn twee boonvormige organen die hoog in de buikholte aan weerszijden van 
de wervelkolom liggen. Ze filteren afvalstoffen uit het bloed en produceren hierbij urine. 
Via de urineleiders (ureters) wordt de urine getransporteerd naar de blaas. De blaas is een 
holle spier die vooraan in het kleine bekken, op de bekkenbodem achter het schaambeen 
ligt. De blaas heeft een cyclus van opslag en lediging. Via de urinebuis (urethra) verlaat de 
urine het lichaam. 
Het overactieve blaassyndroom is een symptomencomplex dat bestaat uit onbedwingbare 
aandrang voor urine, met of zonder urineverlies, meestal gepaard gaande met vaak 
plassen (meer dan 8x per dag) en ’s nachts plassen (minimaal 1x per nacht). Het is een 
veelvoorkomende aandoening die een grote negatieve impact heeft op de kwaliteit 
van leven van de patiënt. Wanneer de holle blaasspier (musculus detrusor) tijdens de 
opslagfase niet ontspannen blijft, maar willekeurig samenknijpt (detrusor overactiviteit), 
kan de patiënt ongewild urine verliezen. Deze onwillekeurige samentrekking wordt meestal 
ervaren als aandrang om te plassen. Een blaasdrukmeting (urodynamisch onderzoek) 
is de huidige gouden standaard om vast te stellen of iemand lijdt aan een overactieve 
blaasspier. Door de blaas langzaam met water te vullen wordt de vullingsfase nagebootst.
Er bestaan verschillende medicijnen om de overactieve blaas te behandelen, maar 
bijwerkingen spelen hierin een grote belemmerende rol. Om nieuwe medicijnen te 
ontwikkelen die specifiek op de ongewenste blaasoveractiviteit ingrijpen, moet men meer 
weten over hoe de blaasspier eigenlijk werkt. Als men op cel- en eiwitniveau het verschil 
kan aantonen tussen een normale en zieke blaasspier, heeft men mogelijk een startpunt 
vanwaaruit specifieke medicijnen kunnen worden ontwikkeld. Men dacht altijd dat de 
blaas een holle spier was die werd aangestuurd door het zenuwstelsel. Pogingen om de 
oorzaak van de overactieve blaas te ontdekken zijn daarom met name gericht geweest 
op een abnormale zenuwaansturing van de blaas. Echter, de laatste tijd komen er steeds 
meer aanwijzingen dat er veranderingen plaatsvinden in de blaasspier zelf, die een rol 
zouden kunnen spelen in het ontstaan van dit ziektebeeld. Zo blijkt dat een overactieve 
Figuur 1 - Schematisch overzicht van de 
urinewegen met de nieren, ureters, blaas 
en urethra (bron: blaasproblemen.nl).
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blaasspier vaak voorkomt bij mannen met een vergrote prostaat, hetgeen niets met een 
abnormale aansturing door het zenuwstelsel te maken heeft. Bij experimenten waarin 
de blaas werd losgekoppeld van het zenuwstelsel, blijkt de blaas spontane spieractiviteit 
te tonen in rust, die bovendien ritmisch van karakter is. De blaas heeft dus een interne 
pacemaker. Dergelijke experimenten met een geïsoleerde blaas lieten zien dat deze 
ritmische spieractiviteit ontregeld is bij de overactieve blaasspier. Deze bevindingen 
duiden op een mogelijke interne bron in de blaasspier voor het ontstaan van detrusor 
overactiviteit en het overactieve blaassyndroom.
Onze onderzoeksgroep startte dit project om de cellulaire eigenschappen van de blaas bij 
mensen met en zonder het overactieve blaas syndroom te analyseren. Ons uitgangspunt 
is dat de onwillekeurige samentrekkingen van de blaasspier bij het overactieve blaas 
syndroom hun oorsprong niet hebben in abnormale aansturing door het zenuwstelsel, 
maar ontstaan door structurele veranderingen in de blaasspier zelf. De blaas is dus geen 
‘zwarte doos’ die simpelweg de instructies van het zenuwstelsel uitvoert.
In hoofdstuk 1 wordt een introductie gegeven van het overactieve blaas syndroom. Tevens 
wordt de gedachtegang achter dit proefschrift uiteen gezet. De werking van de lagere 
urinewegen en de traditionele visie op de samenstelling van de blaas worden beschreven. 
Definities van normale en abnormale werking van het orgaan worden behandeld. We 
demonstreren de omvang van het probleem genaamd het overactieve blaassyndroom en 
bediscussiëren de beperkingen van huidige diagnostische middelen en behandelingen.
In hoofdstuk 2 wordt de complexiteit van de terminologie, evaluatie en behandeling van 
klachten van de lagere urinewegen beschreven. We kunnen deze klachten indelen in 
klachten tijdens de opslagfase van urine, klachten tijdens het plassen en klachten na het 
plassen. We nemen de klachten die aanhouden na behandeling van een vergrote prostaat 
als voorbeeld. De plasbuis loopt door de prostaat heen. Een vergrote prostaat kan de 
uitstroom van urine uit de blaas belemmeren. De aanhoudende klachten na het uithollen 
van een vergrote prostaat, en dus het opheffen van de uitgangsbelemmering, zijn gelijk 
aan de klachten die voorkomen bij het overactieve blaas syndroom. Het blijkt dat andere 
factoren dan het zenuwstelsel dus ook een rol kunnen spelen in het ontstaan van het 
overactieve blaas syndroom. Bovendien rijst de vraag of de blaasspier een mogelijke 
intrinsieke bron heeft voor het ontstaan van detrusor overactiviteit, aangezien overactieve 
blaasklachten dikwijls blijven bestaan na behandeling van de uitgangsbelemmering.
Hoofdstuk 3 geeft een overzicht van de huidige theoriën die detrusoroveractiviteit proberen 
te verklaren. De neurogene, myogene en autonome hypotheses worden beschreven. 
De neurogene theorie suggereert dat detrusoroveractiviteit ontstaat ten gevolge van 
een verandering in de samenwerking tussen het centrale en perifere zenuwstelsel. 
De blaas heeft een zelfstimulerende zenuwreflexboog (perifere zenuwstelsel) die het 
ruggemerg kruist. Vanuit de hersenen en het ruggemerg (centrale zenuwstelsel) wordt 
deze zelfstimulerende reflexboog geremd. Bij bepaalde aandoeningen kan de rem vanuit 
het centrale zenuwstelsel wegvallen, zoals bij een dwarslaesie. Hierdoor ontstaat een 
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ontregeling van de blaasreflexboog, waardoor de blaas overactief wordt. De myogene 
theorie gaat uit van het feit dat er veranderingen plaatsvinden in de blaasspier zelf. Door 
veranderde eigenschappen van de spiercellen zouden de cellen makkelijker kunnen 
samentrekken, waardoor de blaasspier overactief wordt. De autonome theorie gaat uit 
van de autonome samentrekkingen van de blaas. Het blijkt dat de blaas niet alleen actief 
is tijdens de plasfase. Ook in de rustfase trekt de blaas samen. Deze samentrekkingen 
komen echter plaatselijk in de blaaswand voor, waardoor de blaasspier niet als één geheel 
samentrekt en er geen urine wordt verloren. De exacte betekenis van deze activiteit is 
onbekend, maar er wordt gespeculeerd dat de blaas op deze wijze ‘aftast’ in hoeverre 
de blaas gevuld is. Overexpressie van de autonome activiteit zou kunnen resulteren 
in detrusoroveractiviteit. Om deze hypotheses te toetsen, moet de blaas beschouwd 
worden als een complex orgaan met verscheidene regulerende componenten. Omdat er 
relatief weinig bekend is van de cellulaire samenstelling en werking van de blaasspier, 
is gedetailleerd microscopisch onderzoek van de blaasspier een vanzelfsprekende eerste 
stap.
In hoofdstuk 4 onderzoeken we de verbindingen tussen de spiercellen van de menselijke 
blaas. In de meeste organen zijn spiercellen elektrisch en mechanisch met elkaar 
verbonden, waardoor een gecoördineerde samentrekking kan plaats vinden. Connexines 
zijn eiwitten die voorkomen in de celwand van spiercellen. Ze vormen zogenaamde 
gap junctions, ook wel ionkanalen genoemd. Via deze kanalen kunnen kleine geladen 
moleculen (ionen) zich van de ene naar de andere cel verplaatsen en ontstaat er een 
electrische stroom. Deze stroom is nodig voor gecoördineerde samentrekking van de 
spiercellen. Echter, mechanische verbinding tussen de cellen is ook nodig, omdat het 
orgaan anders in stukken wordt getrokken. Gap junctions belichamen slechts een passief 
communicatiekanaal en vormen geen mechanische verbinding. Cadherines zijn eiwitten 
die, net als gap junctions, ook gelokaliseerd zijn in de celwand. Er zijn verschillende 
subtypen van bekend. Cadherines verankeren de celwanden van aangrenzende cellen die 
hetzelfde cadherine subtype tot expressie brengen. We hebben daarom de expressie van 
verschillende cadherines in acht menselijk blazen onderzocht. De biopten zijn afkomstig 
van patiënten bij wie de blaas in zijn geheel is verwijderd in verband met blaaskanker. 
We vonden een gespikkeld patroon van cadherin-11 (een cadherine subtype) op de 
celwand van spiercellen in de menselijke blaas. Cadherin-11 werd ook aangetroffen in 
de celwand van myofibroblasten die net onder de slijmvlieslaag van de binnenzijde van 
de blaas gelokaliseerd zijn. Myofibroblasten zijn een recent ontdekte groep cellen die 
eigenschappen van spiercellen en bindweefselcellen hebben. We zagen dat cadherine-11 
het interne skelet van de cellen met elkaar verbindt. Dit zogenaamde cytoskelet geeft de 
cel stevigheid. We concludeerden daarom dat cadherine-11 de mechanische verankering 
tussen spiercellen en myofibroblasten in de menselijke blaas verzorgt. Het is mogelijk dat 
deze myofibroblasten die onder de slijmvlieslaag liggen functioneren als een soort sensor 
die oprekt bij blaasvulling. Deze cellen zouden daarom sterk verankerd met elkaar moeten 
zijn. 
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In hoofdstuk 5 onderzoeken we of het tellen van het aantal celverankeringen in de 
menselijke blaasspier gebruikt kan worden als een diagnostisch instrument om detrusor 
overactiviteit op te sporen. Deze celverankeringen worden ook wel adherens junctions 
genoemd. Tijdens eerdere onderzoeken met electronenmicroscopie werd gevonden 
dat de overactieve blaasspier een zogenaamd ‘disjunction’ patroon heeft. Dit patroon 
wordt gekarakteriseerd door het gebrek aan verankeringseiwitten tussen de spiercellen 
en een vergrote afstand tussen de cellen die is opgevuld door bindweefselstrengen 
(collageen). We onderzochten 23 patiënten met detrusoroveractiviteit, verdeeld in vier 
groepen, te weten: 5 normale, 6 met detrusor overactiviteit door een zenuwaandoening, 
6 met detrusoroveractiviteit door belemmering van de blaasuitgang en 6 met 
detrusoroveractiviteit door onbekende oorzaak. Middels electronen microscopische 
technieken bevestigden we dat cadherine-11 een integraal  onderdeel is van de 
verankeringseiwitten tussen de spiercellen. In feite belichaamt het gespikkelde patroon 
van cadherine-11 de adherens junctions zoals eerder aangetoond tijdens onderzoeken 
naar het ‘disjunction’ patroon. Cadherin-11 bleek minder voor te komen op spiercellen 
die verder uit elkaar lagen. Echter, cadherine-11 was zeer ongelijkmatig verdeeld tussen 
de verschillende spierbundels van de blaasspier. We vonden geen samenhang tussen 
de hoeveelheid cadherine-11 die voorkwam op de spiercellen en overactiviteit van de 
blaasspier. Daarom concludeerden we dat het tellen van het aantal adherens junctions 
of celverankeringen niet gebruikt kan worden als instrument om overactiveit van de 
blaasspier op te sporen.
In hoofdstuk 6 onderzochten we of N-cadherine, een ander cadherine subtype, kan 
worden gebruikt om interstitiële cellen specifiek te markeren. Interstitiële cellen, ook 
wel myofibroblasten genoemd, spelen waarschijnlijk een grote rol bij het ontstaan van 
een overactieve blaasspier. Ze komen in het bindweefsel van de blaas voor. Men denkt 
dat ze een netwerk van cellen vormen die signalen van verscheidene celtypen in de 
blaaswand integreren. Echter, tot nu toe is er geen goede manier gevonden om deze 
cellen specifiek aan te kleuren en dus aantoonbaar te maken voor analyse. Cadherines 
fungeren als signaleringscentra tussen cellen. N-cadherine is het meest voorkomende 
cadherine in bindweefsel. Zestien blaasbiopten werden onderzocht welke afkomstig 
waren van patiënten bij wie de blaas in zijn geheel was verwijderd in verband met 
blaaskanker. N-cadherine werd aangetoond in sterk vertakte cellen die gelokaliseerd 
waren net onder het slijmlies en in de bindweefsellagen tussen de spierbundels van de 
blaasspier. N-cadherine bleek niet voor te komen in zenuwen of spiercellen. Middels 
electronenmicroscopie vonden we myofibroblasten die identiek leken aan de N-cadherine 
positieve cellen. Echter, er lijken verschillende soorten interstitiële cellen te bestaan in de 
menselijke blaas. We concludeerden daarom dat N-cadherine gebruikt kan worden om 
een subtype van interstitiële cellen te markeren in de menselijke blaas.
In hoofdstuk 7 onderzochten we mogelijke veranderingen van de N-cadherine positieve 
celpopulatie in de overactieve blaaspier. Zoals eerder vermeld suggereert de autonome 
hypothese dat detrusor overactiviteit gezien kan worden als een ontsporing van autonome 
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activiteit van de blaas. Deze autonome activiteit ontspringt in de blaas zelf en verplaatst zich 
al golvend door de blaaswand. Ontsporing van deze activiteit zou niet alleen het resultaat 
kunnen zijn van verhoogde electrische koppeling tussen spiercellen (myogene hypothese), 
maar ook door veranderingen in het netwerk van interstitiële cellen. We onderzochten 
23 patiënten met detrusoroveractiviteit, verdeeld in vier groepen, te weten: 5 normale, 
6 met detrusoroveractiviteit door een zenuwaandoening, 6 met detrusoroveractiviteit 
door belemmering van de blaasuitgang en 6 met detrusor overactiviteit door onbekende 
oorzaak. Het onderzoek toonde aan dat het aantal N-cadherine positieve cellen veranderd 
leek te zijn in overactieve blaasspieren, zonder onderscheid te maken in de oorzaak van 
detrusoroveractiviteit. Tevens vonden we dat in spierbundels waar minder zenuwen 
aanwezig waren, meer N-cadherine positieve cellen leken voor te komen. Zenuwen lopen 
gedeeltelijk de blaaswand in om contact te maken met de blaasspier. Het verdwijnen van 
deze zenuwuiteinden is door meerdere onderzoekers beschreven en lijkt een eigenschap 
te zijn van de overactieve blaasspier, ongeacht de oorzaak. We concludeerden daarom 
dat de groep van N-cadherine positieve cellen in de menselijke blaas de mogelijkheid 
heeft om zich te uit te breiden door de blaaswand. Bovendien speculeerden we dat een 
hoogontwikkeld netwerk van interstitiële cellen het verlies van zenuwen in de overactieve 
blaasspier vervangt. Als dit nieuwe netwerk makkelijker kan worden geactiveerd, zou dit 
detrusoroveractiviteit tot gevolg kunnen hebben.
Het relatief nieuwe onderzoeksveld van het overactieve blaas syndroom is uitdagend omdat 
de blaas veel ingewikkelder in elkaar zit dan we altijd dachten. Er wordt gespeculeerd dat 
overactiviteit van de blaasspier zou kunnen ontstaan in de blaaspier zelf en niet komt door 
een probleem in de zenuwaansturing van de blaas. Bij een grote groep patiënten die lijden 
aan het overactieve blaas syndroom wordt geen duidelijke oorzaak gevonden. Mogelijk 
dat bij hun de oorzaak in de blaas zelf ligt. Dit is echter zuiver speculatie. Ondanks dat er 
de laatste tijd veel vooruitgang is geboekt op wetenschappelijk gebied, blijven veel vragen 
over de werking van de normale en overactieve blaas nog onbeantwoord. Verscheidene 
hypotheses proberen het overactieve blaas syndroom te verklaren en concluderend kan 
worden vastgesteld dat de neurogene noch de myogene theorie het ziektebeeld volledig 
kunnen verklaren. De autonome hypothese is echter veelbelovend en zou het begin van 
een antwoord op de vele vragen kunnen zijn. 
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